<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83865</article-id><article-id pub-id-type="doi">10.7554/eLife.83865</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Modulation of brain signal variability in visual cortex reflects aging, GABA, and behavior</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Lalwani</surname><given-names>Poortata</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3022-3152</contrib-id><email>poortata@umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Polk</surname><given-names>Thad</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Garrett</surname><given-names>Douglas D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0629-7672</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Department of Psychology, University of Michigan</institution></institution-wrap><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Max Planck UCL Centre for Computational Psychiatry and Ageing Research</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pp7px91</institution-id><institution>Center for Lifespan Psychology, Max Planck Institute for Human Development</institution></institution-wrap><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ip</surname><given-names>I Betina</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Gold</surname><given-names>Joshua I</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>University of Pennsylvania</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>17</day><month>04</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e83865</elocation-id><history><date date-type="received" iso-8601-date="2022-09-30"><day>30</day><month>09</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2024-11-30"><day>30</day><month>11</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-09-17"><day>17</day><month>09</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.09.14.507785"/></event></pub-history><permissions><copyright-statement>© 2025, Lalwani et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Lalwani et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83865-v1.pdf"/><abstract><p>Moment-to-moment neural variability has been shown to scale positively with the complexity of stimulus input. However, the mechanisms underlying the ability to align variability to input complexity are unknown. Using a combination of behavioral methods, computational modeling, fMRI, MR spectroscopy, and pharmacological intervention, we investigated the role of aging and GABA in neural variability during visual processing. We replicated previous findings that participants expressed higher variability when viewing more complex visual stimuli. Additionally, we found that such variability modulation was associated with higher baseline visual GABA levels and was reduced in older adults. When pharmacologically increasing GABA activity, we found that participants with lower baseline GABA levels showed a drug-related increase in variability modulation while participants with higher baseline GABA showed no change or even a reduction, consistent with an inverted-U account. Finally, higher baseline GABA and variability modulation were jointly associated with better visual-discrimination performance. These results suggest that GABA plays an important role in how humans utilize neural variability to adapt to the complexity of the visual world.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neural variability</kwd><kwd>GABA</kwd><kwd>aging</kwd><kwd>visual cortex</kwd><kwd>HMAX</kwd><kwd>face / house processing</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>AG068517</award-id><principal-award-recipient><name><surname>Lalwani</surname><given-names>Poortata</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>AG050523</award-id><principal-award-recipient><name><surname>Polk</surname><given-names>Thad</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Humans scale brain signal variability with stimulus complexity to efficiently process visual inputs, an ability reduced in those with poorer visual discrimination and in older adults with lower GABA levels (brain's major inhibitory neurotransmitter), but recoverable by boosting GABA pharmacologically.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Our sensory modalities are constantly processing myriad inputs that differ in complexity across various dimensions. And yet, our neural networks can accommodate and process such heterogeneity. It has been postulated that an efficient neural network may do this by modulating neural dynamics to align with the complexity of input stimuli; neural dynamics would be increased to process more complex stimuli, but compressed to process less complex stimuli (<xref ref-type="bibr" rid="bib32">Hermundstad et al., 2014</xref>; <xref ref-type="bibr" rid="bib50">Orbán et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref>). One neural measure that scales with stimulus complexity and captures this ability is moment-to-moment variability in the blood oxygen level-dependent signal (SD<sub>BOLD</sub>). In fact, research so far has demonstrated that SD<sub>BOLD</sub> is a far more powerful predictor of cognitive abilities than the traditionally used mean-BOLD signal changes (<xref ref-type="bibr" rid="bib22">Garrett et al., 2013b</xref>; <xref ref-type="bibr" rid="bib20">Garrett et al., 2011</xref>; <xref ref-type="bibr" rid="bib27">Grady and Garrett, 2014</xref>) (including in the domain of stimulus selectivity <xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref>). Our recent work (<xref ref-type="bibr" rid="bib36">Krohn et al., 2023</xref>) shows that regional BOLD variability can even drive the strength of functional connectivity measures (another popular fMRI measure). Thus, ‘local dynamics’ being captured by moment-to-moment variability may be a unique and indispensable measure of human brain function in relation to how we align to the complexity of the world around us. In the current study, we examine how human aging affects our ability to align these dynamics to stimulus complexity, and the neurochemical mechanisms subserving such alignment.</p><p>Although age comparisons have not yet been made, recent research only in older adults found that the ability to upregulate visuo-cortical SD<sub>BOLD</sub> when viewing more complex, feature-rich visual stimuli characterized those with better visuo-cognitive performance (<xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref>). These results suggest that upregulation of variability in response to the increased complexity of stimulus input (or <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) may be an index of the flexibility of an individual’s neural system and predict individual differences in sensory processing. Moreover, previous research suggests that the modulation of variability in response to task demands is reduced in older adults compared to younger adults (<xref ref-type="bibr" rid="bib20">Garrett et al., 2011</xref>; <xref ref-type="bibr" rid="bib19">Garrett et al., 2010</xref>; <xref ref-type="bibr" rid="bib21">Garrett et al., 2013a</xref>) and that this reduction is associated with poorer behavioral performance (<xref ref-type="bibr" rid="bib19">Garrett et al., 2010</xref>; <xref ref-type="bibr" rid="bib21">Garrett et al., 2013a</xref>; <xref ref-type="bibr" rid="bib28">Grady and Garrett, 2018</xref>; <xref ref-type="bibr" rid="bib67">Waschke et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Rieck et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Rieck et al., 2022</xref>). We thus hypothesized that <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (expected to scale positively with visual stimulus complexity) would also be lower in older adults and that this reduction would be linked with poorer visual discrimination. But what is the basis of such age-based (and individual) differences in <inline-formula><mml:math id="inf3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>?</p><p>Gamma-aminobutyric acid (GABA), the brain’s major inhibitory neurotransmitter, is one plausible candidate. GABA has been associated with cortical plasticity (<xref ref-type="bibr" rid="bib33">Jones, 1993</xref>; <xref ref-type="bibr" rid="bib30">Hensch et al., 1998</xref>; <xref ref-type="bibr" rid="bib15">Fagiolini et al., 2004</xref>) with pattern complexity (<xref ref-type="bibr" rid="bib47">Monteforte and Wolf, 2010</xref>) and with the dynamic range <xref ref-type="bibr" rid="bib63">Shew et al., 2011</xref>; <xref ref-type="bibr" rid="bib1">Agrawal et al., 2018</xref> of neural networks. Computational work has found that altering the strength of inhibitory connections in artificial neural networks can dramatically affect moment-to-moment dynamics and the number of different states that networks can sample (<xref ref-type="bibr" rid="bib1">Agrawal et al., 2018</xref>). Similarly, decreasing GABA activity pharmacologically in healthy young rats and monkeys leads to a decrease in network dynamics and reduces the number of states visited by the cortical network (<xref ref-type="bibr" rid="bib63">Shew et al., 2011</xref>). In humans, GABA levels are lower in older adults (<xref ref-type="bibr" rid="bib10">Chamberlain et al., 2021</xref>; <xref ref-type="bibr" rid="bib38">Lalwani et al., 2019</xref>; <xref ref-type="bibr" rid="bib64">Simmonite et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Cassady et al., 2019</xref>; <xref ref-type="bibr" rid="bib53">Porges et al., 2017a</xref>; <xref ref-type="bibr" rid="bib9">Chalavi et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Hermans et al., 2018</xref>; <xref ref-type="bibr" rid="bib17">Gao et al., 2013</xref>; <xref ref-type="bibr" rid="bib12">Cuypers et al., 2018</xref>; <xref ref-type="bibr" rid="bib41">Levin et al., 2019</xref>; <xref ref-type="bibr" rid="bib55">Porges et al., 2021</xref>; <xref ref-type="bibr" rid="bib54">Porges et al., 2017b</xref>) and in recent work, we found that overall cortical resting-state SD<sub>BOLD</sub> can be increased in older, poorer performing adults by GABA agonism (<xref ref-type="bibr" rid="bib39">Lalwani et al., 2021</xref>). However, it remains unknown whether GABA provides a principled basis for how humans align brain signal variability to the complexity of visual input, a crucial step for understanding the mechanisms subserving task-relevant variability modulation in the human brain. Under the assumption that temporal dynamic range is required to distinctly represent external stimuli and respond to stimulus complexity (<xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Młynarski and Hermundstad, 2018</xref>), it is plausible that boosting GABA in individuals with lower baseline GABA levels should increase <inline-formula><mml:math id="inf4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, while those with higher baseline levels of GABA would exhibit a decrease in <inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, consistent with an inverted-U effect (<xref ref-type="bibr" rid="bib48">Northoff and Tumati, 2019</xref>).</p><p>Using data from 58 younger (ages 18–25) and 77 older (ages 65–85) adults (see <xref ref-type="fig" rid="fig1">Figure 1</xref> for complete study design), we addressed these various questions using a combination of computational modeling, functional magnetic resonance imaging (fMRI), magnetic resonance spectroscopy (MRS), pharmacological intervention, and behavioral analyses. Specifically, we first utilized a computational model of the visual system (HMAX) to estimate the complexity of visual stimuli seen by participants during fMRI. To examine the GABAergic basis of variability modulation, we then (1) measured baseline visuo-cortical GABA levels using MRS, and (2) used lorazepam (a GABA<sub>A</sub> agonist) to causally increase GABA activity, while assessing visual <inline-formula><mml:math id="inf6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> on and off drug. In a different subset of participants, we computed a latent visual discrimination behavioral score across four offline tasks. We tested whether: (1) neural variability scaled in response to stimulus complexity (SD<sub>BOLD-HOUSES</sub> &gt;SD<sub>BOLD-FACES</sub>) (2) <inline-formula><mml:math id="inf7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was lower in older adults in comparison to young adults; (3) lower <inline-formula><mml:math id="inf8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was associated with lower visual GABA levels measured using MRS; (4) pharmacologically increasing GABA activity increased <inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in those with low GABA levels, and; (5) higher GABA and greater <inline-formula><mml:math id="inf10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> were associated with better visuo-behavioral performance.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Example C1 and C2 activation distributions to house and face stimuli.</title><p>(<bold>A</bold>) Z-scored median activation at C1 for all images in the two stimulus categories (faces in blue, houses in purple) for one orientation and two different scales. (<bold>B</bold>) Z-scored median activation at C2 for all images in both stimulus categories for two different patch sizes. (<bold>C</bold>) t-values comparing house vs. face median activation in layer C1 across four different orientations and 8 scale bands (from smallest to largest receptive field). (<bold>D</bold>) t-values comparing house vs. face median activation in layer C2 for 8 different patch sizes. All p-values for the t-tests are less than 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83865-fig1-v1.tif"/></fig></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>HMAX analysis of visual Stimuli</title><p>We first estimated the complexity (or ‘feature-richness’) of our set of visual stimulus categories (faces and houses) by submitting them to a biologically inspired computational model of visual processing (HMAX; <xref ref-type="bibr" rid="bib59">Riesenhuber and Poggio, 1999</xref>; <xref ref-type="bibr" rid="bib61">Serre et al., 2007a</xref>; <xref ref-type="bibr" rid="bib62">Serre et al., 2007b</xref>; <xref ref-type="bibr" rid="bib60">Serre, 2005</xref>). To anticipate the results, we found that houses were more ‘feature-rich’ than faces in both C1 (corresponding to V1) and C2 layers (corresponding to extrastriate regions), as described in detail below, consistent with (<xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref>; all t-values&gt;10).</p><p>Physiological studies in non-human primates over recent decades have demonstrated that the receptive fields of neurons increase in both size and complexity as we move anteriorly along the ventral visual pathway. These insights are reflected in the biologically inspired, openly available HMAX feedforward model of visual recognition (code source: <ext-link ext-link-type="uri" xlink:href="http://maxlab.neuro.georgetown.edu/hmax.html">http://maxlab.neuro.georgetown.edu/hmax.html</ext-link>). The two earliest layers in this model (S1 and C1) correspond to neurons in primary visual cortex (V1) and the next two layers (S2 and C2) correspond to neurons in extrastriate visual areas (V2/V4).Following <xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref> we used this model to objectively estimate the visual complexity of the two stimulus categories presented during our visual task (houses vs. faces). This model can also generate predictions about which cortical regions should be most sensitive to differences in stimulus complexity in our specific stimulus set. We focused our analyses on the C1 and C2 layers that aggregate the responses of cells in the S1 and S2 layers.</p><p>Layers in the first layer (S1) are modelled using Gabor functions with 16 different size filters (ranging from 7 to 37) corresponding to n x n pixel neighborhoods for four different orientations (Default: –45°, 0°, 45°, 90°). For each orientation and filter size, a model was fit to each image in overlapping windows (50% overlap) resulting in a simple cell response map for all positions within the input image. At the next layer (complex cells in C1), the maximum activity over S1 units corresponding to each orientation is computed separately. Since 16 filter sizes were used, taking the maximum over neighboring pairs of filters results in eight ‘scale bands’. The scale band index corresponds to the spatial neighborhood of S1 cells over which outputs are pooled. For each of the 8 scale-bands and 4 orientations, we calculated a median within-image C1 activation value for each image and then standardized them by computing z-scores. Using t-tests, we compared these within-image median values across the two stimulus categories. The results of these 8 (scales) × 4 (orientations) independent sample t-tests (<xref ref-type="fig" rid="fig1">Figure 1a and c</xref>) indicate that houses consistently produced a larger median C1 activation value than faces across all receptive field sizes.</p><p>In the third layer (S2), a template-matching approach is used. The receptive fields of the S2 cells correspond to a set of universal prototype templates derived from a library of naturalistic stimuli and their activation is computed based on the Euclidean distance between incoming C1 activity from all four orientations and the stored prototype for that S2 cell. For each prototype, an S2 map is computed across all positions at each of the 8 scale bands. The final layer (C2) then takes a global maximum over all scales and positions for each S2 map separately for different neighborhood (patch) sizes. We computed the median activation for each C2 neighborhood size separately and then standardized the results using z-scores. We then compared median activation by faces and houses using eight independent sample t-tests (one for each patch size). We found that house stimuli showed greater median activity compared with faces across different patch sizes (<xref ref-type="fig" rid="fig1">Figure 1b and d</xref>).</p></sec><sec id="s2-2"><title>Visual stimulus complexity and variability modulation in younger and older adults</title><p>To examine whether brain signal variability is modulated in line with visual complexity, we computed the standard deviation of the BOLD signal (SD<sub>BOLD</sub>) during each task condition (houses and faces) within each voxel and participant after extensively pre-processing the fMRI data (see Methods). Using Partial Least Squares (PLS), we found a single significant latent variable (p&lt;0.001) revealing higher SD<sub>BOLD</sub> when viewing houses than faces (SD<sub>BOLD-HOUSES</sub> &gt;SD<sub>BOLD-FACES</sub>), particularly in ventral visual cortex (See <xref ref-type="fig" rid="fig2">Figure 2</xref> for spatial extent peak and <xref ref-type="table" rid="table1">Table 1</xref> for further details). This task-condition effect on SD<sub>BOLD</sub> was significant in both younger (t(57) = 3.43, p&lt;0.001, Cohen’s d=0.45) and older adults (t(76) = 4.15, p&lt;0.001, Cohen’s d=0.47).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Effect of task-condition on SDBOLD.</title><p>(<bold>a</bold>) Bootstrap ratios are thresholded at a value of ≥3.00, which approximates a 99% confidence interval and increase from red to yellow (no regions showed reliable decrease). (<bold>b</bold>) Primary and extended visual cortex show reliably higher variability (Cohen’s <italic>f</italic>=0.46) during the house condition (in blue) than face condition (in pink) in both younger and older adults.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83865-fig2-v1.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Brain regions that exhibited a reliable association between task-condition and SD<sub>BOLD</sub>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Cluster number</th><th align="left" valign="bottom" colspan="3">MNI co-ordinates</th><th align="left" valign="bottom" rowspan="2">Peak threshold (BSR)</th><th align="left" valign="bottom" rowspan="2">Cluster size (in 2 mm voxels)</th><th align="left" valign="bottom" rowspan="2">Cortical region label based on Harvard Oxford Cortical Atlas</th></tr><tr><th align="left" valign="bottom">X</th><th align="left" valign="bottom">Y</th><th align="left" valign="bottom">Z</th></tr></thead><tbody><tr><td align="left" valign="bottom">1</td><td align="left" valign="bottom">26</td><td align="left" valign="bottom">–44</td><td align="left" valign="bottom">–18</td><td align="left" valign="bottom">16.71</td><td align="left" valign="bottom">18565</td><td align="left" valign="bottom">Temporal Occipital Fusiform Cortex Includes parts of Occipital Pole (AAL Label: Calcarine, Lingual), Lingual Gyrus, Temporal Fusiform Cortex, Occipital Fusiform Gyrus, posterior Parahippocampal Gyrus etc.</td></tr></tbody></table></table-wrap></sec><sec id="s2-3"><title>GABA+ levels and modulation of variability</title><p>Raw GABA+/H<sub>2</sub>O levels (measured using MR spectroscopy) were significantly lower in older adults compared to younger adults (t (131.9)=–6.6, p=8e-10, Cohen’s d=1.1). GABA +levels were also significantly lower in older adults compared to younger adults after correcting for tissue-composition differences (t(131.9)=–3.13, p=0.002, Cohen’s d=0.53) after applying Harris et al.’s alpha tissue correction procedure (<xref ref-type="bibr" rid="bib54">Porges et al., 2017b</xref>). These results suggest that the differences in tissue composition do not explain the observed lower GABA levels in older adults. Since, raw GABA+/H2O levels were highly correlated with alpha tissue composition-corrected GABA levels (r(131) = 0.88, p&lt;2.2e-16), all results presented below were based on the raw GABA+/H2O levels. We further confirmed that the strongest task-condition effects on SD<sub>BOLD</sub> are present in the visual cortex and our GABA estimates are also in the task-relevant visual cortex. Thus, we restricted all further analyses within an anatomically defined task-relevant visual mask in all subjects (see Materials and methods) rather than investigate it in the whole-brain and in task irrelevant regions.</p><p>We investigated the role of Age and GABA levels in modulation of brain signal variability during visual task <inline-formula><mml:math id="inf11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>. We found a single significant latent variable (p=0.018) capturing a positive correlation between <inline-formula><mml:math id="inf12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and ventrovisual GABA levels and a negative correlation between <inline-formula><mml:math id="inf13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and age. As is typical when using multivariate PLS <xref ref-type="bibr" rid="bib35">Krishnan et al., 2011</xref>, a <italic>brainscore</italic> was computed for each subject as the dot product between the resulting PLS model brain-pattern (i.e. a vector of brain voxel weights; see Materials and methods) and <inline-formula><mml:math id="inf14"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> at each voxel. <italic>Brainscores</italic> computed within a functional mask based on the SD<sub>BOLD</sub> Task-Condition model (consisting of all significant voxels from <xref ref-type="fig" rid="fig2">Figure 2</xref>) were highly correlated with those computed using the anatomical mask (r(133) = 0.95, p&lt;2.2e-16). Thus, we used the brain pattern based on the entire anatomical mask for all further analysis which allows for better reproducibility in future studies.</p><p>Both age (F(1,120) = 62.8, p&lt;1.3e-12, Cohen’s <italic>f</italic>=0.71) and GABA (F(1,120) = 7.01, p=0.009, Cohen’s <italic>f</italic>=0.22) also remained robustly associated with visual <inline-formula><mml:math id="inf15"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> after accounting for gray-matter volume differences. Higher GABA levels were similarly associated with greater <inline-formula><mml:math id="inf16"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in both younger (r(50) = 0.34, p=0.01) and older adults (r(71) = 0.25, p=0.04) even after controlling for gray-matter volume differences. An Age x GABA interaction was not significant, <italic>F</italic>(1,120) = 1.07, p=0.3; (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). The regions exhibiting a robust relationship (using 1000 bootstraps) between <inline-formula><mml:math id="inf17"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and GABA levels were in the bilateral fusiform, calcarine and lingual cortex (see <xref ref-type="fig" rid="fig3">Figure 3b</xref> for spatial extent and <xref ref-type="table" rid="table2">Table 2</xref> for cluster details). These results suggest that individual differences in GABA levels play a role in how individuals modulate brain signal variability. Further, we found that tissue-composition corrected auditory GABA +levels (see <xref ref-type="bibr" rid="bib38">Lalwani et al., 2019</xref> for details of voxel placement) were not associated with modulation of visual variability in the whole sample after controlling for age (F(1,120) = 0.72, p=0.4) or within older adults alone (r(74) = 0.01, p=0.9). Similarly, tissue-composition corrected motor GABA +levels (see <xref ref-type="bibr" rid="bib8">Cassady et al., 2019</xref> for details of voxel placement) were not associated with modulation of visual variability in the whole sample after controlling for age (F(1,120) = 0.52, p=0.47) or within older adults alone (r(74) = 0.02, p=0.9), revealing that our GABA +effects were specific to visual cortex.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Brain regions that exhibited a reliable association between age, GABA and <inline-formula><mml:math id="inf18"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> .</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Cluster number</th><th align="left" valign="bottom" colspan="3">MNI co-ordinates</th><th align="left" valign="bottom" rowspan="2">Peak threshold (BSR)</th><th align="left" valign="bottom" rowspan="2">Cluster size (in 2 mm voxels)</th><th align="left" valign="bottom" rowspan="2">Cortical region label based on Harvard Oxford Cortical Atlas</th></tr><tr><th align="left" valign="bottom">X</th><th align="left" valign="bottom">Y</th><th align="left" valign="bottom">Z</th></tr></thead><tbody><tr><td align="left" valign="bottom">1</td><td align="left" valign="bottom">–28</td><td align="left" valign="bottom">–78</td><td align="left" valign="bottom">-6</td><td align="left" valign="bottom">5.35</td><td align="left" valign="bottom">118</td><td align="left" valign="bottom">Occipital Fusiform Gyrus</td></tr><tr><td align="left" valign="bottom">2</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">–92</td><td align="left" valign="bottom">2</td><td align="left" valign="bottom">5.05</td><td align="left" valign="bottom">124</td><td align="left" valign="bottom">Bilateral Occipital Pole (AAL Label: Calcarine and Lingual)</td></tr><tr><td align="left" valign="bottom">3</td><td align="left" valign="bottom">24</td><td align="left" valign="bottom">–70</td><td align="left" valign="bottom">-8</td><td align="left" valign="bottom">4.69</td><td align="left" valign="bottom">199</td><td align="left" valign="bottom">Occipital Fusiform Gyrus</td></tr></tbody></table></table-wrap><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Higher GABA +levels are associated with greater <inline-formula><mml:math id="inf19"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> .</title><p>(<bold>a</bold>) Higher multivariate <inline-formula><mml:math id="inf20"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> is associated with younger adult age (Cohen’s <italic>f</italic>=0.71) and with greater GABA +levels (Cohen’s <italic>f</italic>=0.22) in both older (in blue) and younger adults (in pink). (<bold>b</bold>) Relationship between <inline-formula><mml:math id="inf21"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and GABA levels is robust in primary visual cortex and fusiform gyrus. Bootstrap ratios are thresholded at a value of ≥3.00, which approximates a 99% confidence interval and increase from red to yellow.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83865-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title>Effect of GABA agonism on <inline-formula><mml:math id="inf22"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula></title><p>To examine a more causal role of GABA, we administered lorazepam (a benzodiazepine known to potentiate the activity of GABA) in a subset of our participants (25 older and 20 younger adults). Masking by the same brain-pattern from the GABA–<inline-formula><mml:math id="inf23"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> model shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, we estimated the influence of drug on <inline-formula><mml:math id="inf24"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (<inline-formula><mml:math id="inf25"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi><mml:mo>−</mml:mo><mml:mi mathvariant="normal">D</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> – <inline-formula><mml:math id="inf26"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi><mml:mo>−</mml:mo><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">o</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) and its relationship with baseline GABA +levels estimated during MRS-session (off-drug). Consistent with a GABAergic inverted-U account, we found that baseline GABA levels measured using MRS were negatively associated with the drug-related shift in <inline-formula><mml:math id="inf27"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (F (1,37)=7.85, p=0.008, Cohen’s <italic>f</italic>=0.42) across all subjects (see <xref ref-type="fig" rid="fig4">Figure 4</xref>), even after accounting for age, dosage, days between two sessions, order of sessions, and gray-matter volume differences. Age-Group did not interact with GABA level (F (1,37)=0.9, p=0.36).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Drug-related shift in <inline-formula><mml:math id="inf28"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> is associated with baseline GABA +levels measured using MRS (off-drug).</title><p>GABA agonism leads to an increase in <inline-formula><mml:math id="inf29"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in participants with lower GABA levels, while those with higher GABA levels exhibit a decrease in <inline-formula><mml:math id="inf30"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (Cohen’s <italic>f</italic>=0.42) in both older adults (in blue) and younger adults (in pink).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83865-fig4-v1.tif"/></fig><p>Drug dosage was randomly assigned across participants independent of their baseline GABA levels, age or weight, such that 6 older and 7 younger participants received the 1 mg dosage. Baseline GABA levels across participants with 1 mg dosage did not differ significantly from those with 0.5 mg dosage in older (t(6) = –0.7, p=0.5) or younger adults (t(13) = –1.5, p=0.2). Moreover, the drug-related shift in <inline-formula><mml:math id="inf31"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> did not differ significantly between participants who received 0.5 mg (Mean = 0.6) vs 1 mg (Mean = –2.0) dosage (t(20) = 1.6, p=0.13). These dosage effects are in the expected direction, but these findings should be interpreted with caution as only a small number (n=13) of participants received the 1 mg dosage of the drug and we are underpowered to detect the dosage-dependant effects on GABA-related shifts in <inline-formula><mml:math id="inf32"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>. Regardless, the relationship between baseline GABA levels and the drug-related shift in <inline-formula><mml:math id="inf33"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> is significant even after controlling for the drug dosage in older adults (Pearson Correlation r(25) = –0.54, p=0.006).</p><p>Finally, the average effect of drug on <inline-formula><mml:math id="inf34"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was not significant (F (1,44)=0.04, p=0.85), unsurprisingly because adults with lower baseline GABA exhibited a drug-related increase in <inline-formula><mml:math id="inf35"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, while those with higher baseline GABA showed a drug-related decrease.</p></sec><sec id="s2-5"><title>GABA+, <inline-formula><mml:math id="inf36"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>, and behavior</title><p>To investigate associations between behavior and both <inline-formula><mml:math id="inf37"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and GABA levels, a different subset of our participants (38 older and 36 younger adults) also completed four visual discrimination tasks: Buildings-in-noise, Faces-in-noise, Objects-in-noise and Scenes-in-noise. Using factor analysis, we computed a single latent factor score based on all these tasks (all loadings were positive; see Materials and methods).</p><p>We also observed a significant Age-Group x GABA level interaction on visual discrimination behavior, even after controlling for gray matter volume (F(1,65) = 7.13, p=0.01, Cohen’s <italic>f</italic>=0.3). On examining the interaction further (See <xref ref-type="fig" rid="fig5">Figure 5a</xref>), we found that GABA levels were more strongly associated with better visual performance in younger adults (rho(30) = 0.62, p=0.0002, <italic>Spearman’s correlation</italic>) than in older adults (rho(36) = 0.37, p=0.022). Regardless, higher GABA levels were associated with better visual performance in both younger and older adults.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Visual sensory function, GABA +levels, and <inline-formula><mml:math id="inf38"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>.</title><p>(<bold>a</bold>) Greater visual sensory scores are significantly associated with higher GABA levels in older adults (in blue) (rho(36) = 0.41) and younger adults (in pink) (rho(30) = 0.62). (<bold>b</bold>) Higher visual sensory scores were also significantly associated with <inline-formula><mml:math id="inf39"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in older adults (rho(36) = 0.41) but not in younger adults.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83865-fig5-v1.tif"/></fig><p>We also found that the <italic>Brainscores,</italic> computed from the previously presented GABA–<inline-formula><mml:math id="inf40"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> model, were significantly associated with visual performance in the older (rho(36) = 0.41, p=0.01), but not younger group (rho(33) = 0.002, p=0.99; see <xref ref-type="fig" rid="fig5">Figure 5b</xref>) and that the Age-Group x <italic>Brainscore</italic> interaction was significant (F(1,68) = 4.84, p=0.03, Cohen’s <italic>f</italic>=0.23), even after controlling for gray matter volume. Thus, both greater <inline-formula><mml:math id="inf41"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and higher GABA levels were associated with better visual discrimination performance in older adults.</p><p>Since, both <inline-formula><mml:math id="inf42"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and GABA levels were associated with visual discrimination performance in older adults, we applied a hierarchical regression to compare a model explaining visual discrimination performance based on GABA levels alone (F(1,36) = 9.3, p=0.004, Adj. R<sup>2</sup>=0.18) to one including both <inline-formula><mml:math id="inf43"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (F(1, 35)=10.42, p=0.003) and GABA levels (F(1,35) = 7.2, p=0.01; Total Model: F(2,35) = 8.8, p=0.0008, Adj. R<sup>2</sup>=0.3). We found that the model including both <inline-formula><mml:math id="inf44"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and GABA explained significant variance over and above that explained by model based on GABA alone (F(1,35) = 6.8, p=0.01, Cohen’s <italic>f</italic>=0.4) suggesting that <inline-formula><mml:math id="inf45"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> captures individual differences in visual sensory function beyond those related to differences in GABA levels in older adults.</p></sec><sec id="s2-6"><title>Results without excluding outliers</title><p>No outliers were determined using Cook’s Distance (=4/sample size) in the model examining the role of task on SD<sub>BOLD</sub> or the role of baseline GABA in drug-related shifts in <inline-formula><mml:math id="inf46"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>. In the linear model investigating the role of Age and GABA on <inline-formula><mml:math id="inf47"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, we found similar effects with and without excluding nine outliers determined by Cook’s Distance. Both age (F(1,129) = 54.73, p&lt;1.6e-11, Cohen’s <italic>f</italic>=0.62) and GABA levels (F(1,129) = 7.03, p=0.009, Cohen’s <italic>f</italic>=0.21) had a significant effect on this <italic>Brainscore</italic> even after accounting for gray-matter volume differences. Higher GABA levels were associated with greater <inline-formula><mml:math id="inf48"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in both older and younger adults and the Age x GABA interaction was not significant (F(1,129) = 0.0004, p=0.98).</p><p>The model investigating the role of GABA in visual discrimination found that GABA had a significant effect on the visual performance latent score after controlling for age and gray matter volume (F(1,69) = 9.7, p=0.003, Cohen’s <italic>f</italic>=0.34). However, the Age-Group x GABA interaction (F(1,69) = 0.74, p=0.39) was not significant. There were four young outliers with Cook’s Distance greater than 0.054 (4/sample size). Nonetheless, the relationship between GABA and visual performance was significant in both age-groups, with or without outliers.</p><p>The <italic>Brainscores</italic> computed from the GABA–<inline-formula><mml:math id="inf49"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> model were significantly associated with the latent visual performance score without excluding the outlier (F(1,69) = 4.2, p=0.04, Cohen’s <italic>f</italic>=0.21). The Age-Group x <italic>Brainscore</italic> interaction however showed a trend towards significance (F(1,69) = 3.6, p=0.06). One young outlier subject was determined as an outlier using Cook’s Distance greater than 0.054 (4/sample size) and excluded from the results presented in the manuscript. Nonetheless, the correlation was significant only in older adults after controlling for age and gray matter volume (rho(37) = 0.41, p=0.01) but not in younger adults with (rho(34) = –0.01, p=0.95) and without the outlier (r(33) = –0.003, p=0.99).</p></sec><sec id="s2-7"><title>Results after controlling for visual acuity</title><p>Raw visual acuity (as measured by the NIH Visual Acuity task) was significantly lower in older adults (t(56.5)=3.85, p=0.0002), but it was not correlated with visual discrimination behavior score (r(72) = –0.03, p=0.78). This is not surprising as the discrimination task was performed with images presented at a comfortable distance and size to the participant. Moreover, controlling for visual acuity did not alter any of the reported effects. Both age (F(1,119) = 67.01, p&lt;3.4e-13) and GABA (F(1,119) = 5.9, p=0.016) remained robustly associated with visual <inline-formula><mml:math id="inf50"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> after controlling for visual acuity and grey matter volume. Moreover, even after controlling for visual acuity and grey matter volume, both greater <inline-formula><mml:math id="inf51"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (rho (36)=0.41, p=0.01) and higher GABA levels (rho (36)=0.35, p=0.03) were associated with better visual discrimination performance in older adults.</p></sec><sec id="s2-8"><title>MEAN<sub>BOLD</sub></title><p>Typically, SD<sub>BOLD</sub> effects are spatially and statistically distinct from MEAN<sub>BOLD</sub> effects in the literature (e.g. <xref ref-type="bibr" rid="bib19">Garrett et al., 2010</xref>; <xref ref-type="bibr" rid="bib20">Garrett et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Garrett et al., 2013a</xref>; <xref ref-type="bibr" rid="bib22">Garrett et al., 2013b</xref>; <xref ref-type="bibr" rid="bib23">Garrett et al., 2015</xref>). To confirm this in the present sample, we examined <inline-formula><mml:math id="inf52"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> computed as the difference between MEAN<sub>BOLD-HOUSE</sub> and MEAN<sub>BOLD-FACE</sub> at each voxel. We found that while <inline-formula><mml:math id="inf53"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was lower in younger adults (F(1,129) = 36, p&lt;1.86e-08) in some similar regions as <inline-formula><mml:math id="inf54"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (see <xref ref-type="fig" rid="fig6">Figure 6</xref> below), <inline-formula><mml:math id="inf55"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was not related to GABA +levels overall (F(1,129) = 1.6, p=0.21), nor in young (r(55) = –0.02, p=0.88) or older adults (r(75) = –0.17, p=0.13). Moreover, <inline-formula><mml:math id="inf56"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was also not related to visual-discrimination performance in older (r(36) = –0.24, p=0.14) or younger adults (r(34) = –0.06, p=0.7).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><inline-formula><mml:math id="inf57"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and GABA +levels.</title><p>(<bold>a</bold>) Higher multivariate <inline-formula><mml:math id="inf58"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> is associated with older adult age (F(1,129) = 36, p &lt; 0.001) but not with GABA +levels in older (in blue) and younger adults (in pink). (<bold>b</bold>) Relationship between <inline-formula><mml:math id="inf59"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and Age is robust in primary visual cortex and fusiform gyrus. Bootstrap ratios are thresholded at a value of ≥3.00, which approximates a 99% confidence interval and increase from red to yellow.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83865-fig6-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We report five main findings. First, brain signal variability in the visual cortex was modulated during various task conditions (greater when viewing more complex houses vs. less complex faces). Second, this modulation of variability (<inline-formula><mml:math id="inf60"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) and MRS-based GABA measures in the ventrovisual cortex were both significantly lower in older adults than in younger adults. Third, individual differences in <inline-formula><mml:math id="inf61"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> were significantly associated with GABA levels in the ventrovisual cortex. Fourth, participants with low GABA-levels tended to exhibit a drug-related increase in <inline-formula><mml:math id="inf62"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, while those with high GABA-levels tended to exhibit a drug-related decrease. Fifth, both higher GABA levels and greater <inline-formula><mml:math id="inf63"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in the visual cortex were associated with better visual function in older adults. We discuss each of these findings in turn below.</p><sec id="s3-1"><title>Visuo-cortical SD<sub>BOLD</sub> aligns with stimulus complexity and is lower in older adults</title><p>Consistent with prior research in older adults by <xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref>, we replicated the finding that BOLD signal variability (SD<sub>BOLD</sub>) is modulated based on the complexity of visual stimuli. SD<sub>BOLD</sub> in response to more ‘feature-rich’ house stimuli was greater than in response to simpler face stimuli in the visual cortex. Future research should investigate other types of stimuli (videos, objects, scenes etc.) to quantify a parametric response in SD<sub>BOLD</sub> to feature richness in the visual cortex. Our current findings support the hypothesis that neural activity in the visual system should exhibit greater dynamic range in response to more complex input (<xref ref-type="bibr" rid="bib66">van Hateren, 1992</xref>; <xref ref-type="bibr" rid="bib68">Waschke, 2023</xref>). Indeed, greater variance in stimulus features has been argued to drive salience in the visual system (<xref ref-type="bibr" rid="bib32">Hermundstad et al., 2014</xref>), which in turn could lead to an increase in resource allocation. It is hypothesized that the visual system (a) reduces resource allocation (narrowing neural dynamic range) when stimulus input is more reducible or less feature rich (here, faces), while it (b) upregulates dynamic range when stimulus input is more differentiated or feature rich (here, houses). Such upregulation of variability in response to the complexity of sensory input may reflect a well-adapted, dynamic neural network, akin to a ‘well-adapted organism’, as discussed by <xref ref-type="bibr" rid="bib42">Marzen and DeDeo, 2017</xref>. Our finding that older adults were less able than younger adults to align neural variability to the complexity of visual input also converges with several previous studies showing that across-domain task-based variability modulation is increasingly muted with age (<xref ref-type="bibr" rid="bib20">Garrett et al., 2011</xref>; <xref ref-type="bibr" rid="bib19">Garrett et al., 2010</xref>; <xref ref-type="bibr" rid="bib21">Garrett et al., 2013a</xref>). Older adults may indeed be less able to adapt to processing demands in their environment (<xref ref-type="bibr" rid="bib22">Garrett et al., 2013b</xref>; <xref ref-type="bibr" rid="bib67">Waschke et al., 2021</xref>).</p></sec><sec id="s3-2"><title>The GABAergic basis of neural variability modulation</title><p>In line with our assumptions, we found that lower baseline GABA levels in the ventrovisual cortex were significantly associated with lower <inline-formula><mml:math id="inf64"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> during visual processing in both young and older adults. Though both GABA levels and brain signal variability decline with age this relationship was significant even after controlling for age and tissue composition. This suggests that GABA levels play a role in individual differences in brain signal variability beyond the effects of age or tissue composition. Moreover, we found that this relationship was specific to visual cortex (i.e. auditory and motor GABA levels did not predict individual differences in visual <inline-formula><mml:math id="inf65"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>). How does the brain’s inhibitory activity (as measured by GABA levels here) play a role in modulation of brain signal variability? Computational modelling and animal research provide multiple in-roads.</p><p>Having sufficient inhibitory activity to offset excitatory activity has been found to be essential to allow artificial neural networks to operate near so-called criticality (<xref ref-type="bibr" rid="bib63">Shew et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Poil et al., 2012</xref>), allowing them to visit a variety of different network states, exhibiting higher dynamic range (<xref ref-type="bibr" rid="bib1">Agrawal et al., 2018</xref>) and brain signal variability (<xref ref-type="bibr" rid="bib39">Lalwani et al., 2021</xref>). Our finding that GABA (the brain’s major inhibitory neurotransmitter) is related to brain signal variability is consistent with this finding. A flexible neural network which can sample a higher number of network states would be able represent different stimuli using a wider variety of different states - leading to more distinct representations of stimuli from each other. Consistent with this hypothesis, lower visual GABA levels in older adults have been associated with less differentiated responses to different visual stimuli in primates (<xref ref-type="bibr" rid="bib40">Leventhal et al., 2003</xref>) and humans (<xref ref-type="bibr" rid="bib10">Chamberlain et al., 2021</xref>). Our results extend these findings and suggest that lower GABA levels in older adults underlie a reduced ability to align neural variability to stimulus complexity, yielding impoverished stimulus differentiation in the older adult brain.</p><p>We proceeded to test the role of GABA in <inline-formula><mml:math id="inf66"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> more causally by administering lorazepam, a benzodiazepine known to potentiate GABA activity at GABA<sub>A</sub> receptors. Indeed, previous research in rodents noted that manipulating GABA levels in healthy rodents leads to a change in neural variability (<xref ref-type="bibr" rid="bib63">Shew et al., 2011</xref>). We found in humans that the drug-related shift in <inline-formula><mml:math id="inf67"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> could be either positive or negative, while being negatively related to baseline GABA. Thus, boosting GABA activity with drug in participants with lower baseline GABA levels and low levels of <inline-formula><mml:math id="inf68"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> resulted in an increase in <inline-formula><mml:math id="inf69"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (i.e. a positive change in <inline-formula><mml:math id="inf70"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> on drug compared to off drug). However, in participants with higher baseline GABA levels and higher <inline-formula><mml:math id="inf71"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, when GABA was increased (perhaps beyond optimal levels), participants experienced no-change or even a decrease in <inline-formula><mml:math id="inf72"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> on drug. These findings thus provide the first evidence in humans for an inverted-U account of how GABA may link to variability modulation.</p><p>Boosting low GABA levels in older adults helps increase <inline-formula><mml:math id="inf73"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, but why does increasing GABA levels lead to reduced <inline-formula><mml:math id="inf74"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in those with higher baseline GABA levels? One explanation is that higher than optimal levels of inhibition can lead to dampening of the entire network. This reduced neuronal firing decreases the number of states the network can visit and decreases the dynamic range of the network. Indeed, some anesthetics work by increasing GABA activity (for example propofol a general anesthetic modulates activity at GABA<sub>A</sub> receptors) and GABA is known for its sedative properties. Previous research showed that propofol leads to a steeper power spectral slope (a measure of the ‘construction’ of signal variance) in monkey ECoG recordings (<xref ref-type="bibr" rid="bib18">Gao et al., 2015</xref>). Networks function optimally only when dynamics are stabilized by appropriate levels of inhibition. Thus, there is an inverted-U relationship between <inline-formula><mml:math id="inf75"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and GABA that is similar to that observed with other neurotransmitters.</p><p>It is important to note that past work arguing for the presence of neurochemical inverted-U effects in humans has rarely estimated baseline neurochemical levels in specific brain regions prior to pharmacological manipulation, instead often relying on simple genotyping as a baseline estimate (e.g. COMT as a proxy for baseline dopamine <xref ref-type="bibr" rid="bib2">Bäckman et al., 2006</xref>) or invasive PET-based imaging (<xref ref-type="bibr" rid="bib11">Cools et al., 2009</xref>). MR spectroscopy may provide the easiest, regionally-specific baseline estimate of GABA for future tests of the GABAergic inverted-U.</p></sec><sec id="s3-3"><title>Higher GABA and variability modulation reflect better visual discrimination</title><p>If GABA and modulation of neural variability indeed help the brain better differentiate visual stimuli, then both should also manifest in better visual discrimination performance. Consistent with this hypothesis, we found that higher ventral visual GABA levels and higher <inline-formula><mml:math id="inf76"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> were both associated with better latent visual discrimination in-noise performance across different stimulus categories (buildings, faces, scenes, and objects). The GABA-behavior relationship was present in both age groups and is consistent with the hypothesis that older adults who maintain neurochemical levels comparable to those in younger adults experience fewer age-related impairments (<xref ref-type="bibr" rid="bib49">Nyberg et al., 2012</xref>; <xref ref-type="bibr" rid="bib5">Bruffaerts et al., 2019</xref>). Notably, <inline-formula><mml:math id="inf77"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:msub><mml:mi mathvariant="normal">N</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> was not related to visual discrimination or GABA levels in young or older adults, further revealing <inline-formula><mml:math id="inf78"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> as a unique behaviorally and neurochemically relevant signature of brain function.</p><p>The role of GABA in visual performance is consistent with previous research which found that GABA levels in the primary visual cortex are associated with better orientation discrimination in neurons in corresponding early visual processing areas (<xref ref-type="bibr" rid="bib37">Kurcyus et al., 2018</xref>) and with improved fluid processing ability (<xref ref-type="bibr" rid="bib64">Simmonite et al., 2019</xref>). Individual differences in GABA levels in other brain areas are also linked with better sensory performance. For example, sensorimotor GABA levels predict motor function (<xref ref-type="bibr" rid="bib8">Cassady et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">Levin et al., 2019</xref>), auditory GABA levels predict hearing loss (<xref ref-type="bibr" rid="bib18">Gao et al., 2015</xref>; <xref ref-type="bibr" rid="bib13">Dobri and Ross, 2021</xref>), and fronto-parietal GABA levels predict cognitive function across multiple domains assessed by higher MOCA scores (<xref ref-type="bibr" rid="bib53">Porges et al., 2017a</xref>). The current work adds to this literature by demonstrating a behaviorally relevant and distinct role of GABA in the modulation of neural variability during visual processing.</p><p>Moreover, not only is greater task-based modulation of neural variability associated with better behavioral performance across a variety of general cognitive domains (<xref ref-type="bibr" rid="bib19">Garrett et al., 2010</xref>; <xref ref-type="bibr" rid="bib21">Garrett et al., 2013a</xref>; <xref ref-type="bibr" rid="bib28">Grady and Garrett, 2018</xref>; <xref ref-type="bibr" rid="bib67">Waschke et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Rieck et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Rieck et al., 2022</xref>), we show that the ability to align variability to stimulus complexity (<inline-formula><mml:math id="inf79"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) reflects visual discrimination directly, especially in older adults. Together, our results highlight the potential of targeting GABA activity in older adults with lower GABA levels to improve stimulus representations as characterized by <inline-formula><mml:math id="inf80"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula><sub>,</sub> and in turn, visual processing.</p><p>We also found that within older adults, <inline-formula><mml:math id="inf81"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> explains variance in visual task performance beyond that explained by GABA. What might underlie these individual differences in older adults? Previous research has found that not only GABA, but dopamine levels also affect the modulation of variability during visual tasks (<xref ref-type="bibr" rid="bib25">Garrett et al., 2022</xref>). Animal research also suggests that excitatory/inhibitory (E/I) <italic>balance</italic> plays a critical role in network flexibility (<xref ref-type="bibr" rid="bib1">Agrawal et al., 2018</xref>). Thus, the level of excitatory neurochemicals (e.g. glutamate) might also be an important factor in age-related changes in sensory processing. Therefore, we hypothesize that along with GABA, other age-related neurochemical changes might also underlie individual differences in <inline-formula><mml:math id="inf82"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and visual processing. A direct comparison of the role of dopamine, GABA, and glutamate would be ideal in future work.</p><p>The current research focused on understanding the role of GABA and <inline-formula><mml:math id="inf83"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in visual processing. However, previous research has highlighted the role of higher <inline-formula><mml:math id="inf84"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in better performance in other cognitive domains such as processing speed (<xref ref-type="bibr" rid="bib21">Garrett et al., 2013a</xref>) and memory (<xref ref-type="bibr" rid="bib25">Garrett et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Garrett et al., 2015</xref>), while lower SD<sub>BOLD</sub> has been related to age-linked pathologies like Alzheimer’s disease (<xref ref-type="bibr" rid="bib45">Millar et al., 2020</xref>; <xref ref-type="bibr" rid="bib71">Zhang et al., 2020</xref>). Separately, researchers have also found a link between dysfunction in GABAergic signaling and AD (<xref ref-type="bibr" rid="bib6">Calvo-Flores Guzmán et al., 2018</xref>) as well as poor cognitive functions (<xref ref-type="bibr" rid="bib53">Porges et al., 2017a</xref>) as described above. Investigating if age-related changes in GABA and <inline-formula><mml:math id="inf85"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> underlie these pathologies and cognitive decline might hold promise for developing new pharmacological targets to alleviate age-linked impairments.</p></sec><sec id="s3-4"><title>Limitations</title><p>One limitation of the current study is that participants who received the drug-manipulation did not complete the visual discrimination task, thus we could not directly assess how the drug-related change in SD<sub>BOLD</sub> impacted visual performance. Another important limitation is that the age comparisons were all cross-sectional. We therefore cannot rule out cohort effects which may have contributed to the observed differences between the young and older adults. MR spectroscopy also has limitations: (1) it only captures the baseline availability of GABA and (2) we are only able to measure the GABA +MM signal, an approximation of GABA using a standard MEGA-PRESS sequence that contains contamination from macromolecules (see Materials and methods). Although previous research has found GABA estimates using a special MM-suppression sequence and the GABA +MM signal from MEGA-PRESS to be correlated, there are regional and individual differences (see <xref ref-type="bibr" rid="bib29">Harris et al., 2015</xref> for discussion on the relationship between GABA +and MM-suppressed GABA measures and how this relationship can vary across regions). Moreover, the MM signal, while often assumed to be functionally irrelevant, shows inter-individual differences and age-related differences that can limit the interpretations of our results.</p></sec><sec id="s3-5"><title>Conclusion</title><p>Our results suggest that GABA plays a key role in how humans of different ages modulate neural variability to adapt to the complexity of the visual world. The results suggest that interventions targeting inhibitory systems could potentially slow sensory and variability-based declines characteristic of older adults, a key goal for future work.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>This data was collected as part of the Michigan Neural Distinctiveness (MiND) study. Here, we only describe the portions of the study that are relevant to this analysis. For details about the entire study protocol see <xref ref-type="bibr" rid="bib16">Gagnon et al., 2019</xref>. The ethical approval for the study was granted by the Institutional Review Board of The University of Michigan (HUM00103117).</p><sec id="s4-1"><title>Participants</title><p>We analyzed the data from 58 young (age 18–29 years) and 77 older (age 65 and above) adults who completed the entire MiND study before the start of the COVID-19 pandemic. All participants were recruited from Ann Arbor and the surrounding area, were right-handed, native English speakers, and had normal or corrected to normal vision. We screened out participants who scored 23 or lower on the Montreal Cognitive Assessment (MOCA) (<xref ref-type="bibr" rid="bib7">Carson et al., 2018</xref>). All the sessions described below took place at the University of Michigan’s Functional MRI Laboratory, Ann Arbor, Michigan. The following were subject inclusion and exclusion criteria:</p><p>a. Study Inclusion Criteria</p><list list-type="bullet" id="list1"><list-item><p>Age 18–29 years or 65 years and older</p></list-item><list-item><p>Right-handed</p></list-item><list-item><p>Native English speaker</p></list-item><list-item><p>Healthy (i.e. no debilitating conditions, mental illness, or head trauma)</p></list-item></list><p>b. Study Exclusion Criteria</p><list list-type="bullet" id="list2"><list-item><p>Glaucoma</p></list-item><list-item><p>Respiratory problems</p></list-item><list-item><p>Benzodiazepine allergy</p></list-item><list-item><p>Past or present chemotherapy</p></list-item><list-item><p>Immune system disorder</p></list-item><list-item><p>Kidney or liver disease</p></list-item><list-item><p>Hearing problems or use of a hearing aid</p></list-item><list-item><p>Color blindness</p></list-item><list-item><p>Motor control problems</p></list-item><list-item><p>Psychotropic medication</p></list-item><list-item><p>Current depression or anxiety, or occurrence of depression/anxiety within 5 years</p></list-item><list-item><p>Concussion with unconsciousness for 5 min or more</p></list-item><list-item><p>Pregnancy or attempting to become pregnant</p></list-item><list-item><p>More than four alcoholic drinks per week for women, more than six for men</p></list-item><list-item><p>History of drug or alcohol abuse or addiction</p></list-item><list-item><p>Weight greater than 250 pounds</p></list-item><list-item><p>MRI incompatibility (claustrophobic, foreign metallic objects, pacemaker, etc)</p></list-item></list></sec><sec id="s4-2"><title>Power analysis</title><p><xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref> found a correlation of <italic>r</italic>=0.47 between modulation of visual variability and behavioral performance within older adults. In our convenience sample of those who completed the study before the pandemic and who completed the behavioral tasks (Subset 3), we had 80% power to detect a correlation of <italic>r</italic>=0.47 in each age-group alone.</p></sec><sec id="s4-3"><title>Session design</title><p>After completing an initial telephone screening interview and being determined eligible, all subjects participated in three sessions, each on a separate day. Session 1 only involved cognitive and behavioral testing, session 2 included a functional magnetic resonance imaging (fMRI) scan, and session 3 only involved a Magnetic Resonance Spectroscopy (MRS) scan (See <xref ref-type="fig" rid="fig7">Figure 7</xref> for summary).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Session design and participant distribution.</title><p>All participants underwent an fMRI and MRS scanning session on separate days. One subset of participants (25 older and 20 younger) received an additional on-drug fMRI scan on a separate day. The order of on-drug and off-drug fMRI sessions was randomized. A different subset (3) of participants (38 older and 36 younger) completed four visual discriminatory tasks on a separate day before fMRI testing. During the fMRI session participants completed a 6-min visual task with pseudorandomized 20 s blocks of passively viewed houses and faces interleaved with 10 s fixation blocks as shown in the green panel. Change in variability (<inline-formula><mml:math id="inf86"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) is computed at every voxel as the difference between SD<sub>BOLD-HOUSES</sub> and SD<sub>BOLD-FACES</sub>. The orange panel shows the MRS voxel overlap across participants with brighter (yellow) indicating maximum overlap and red showing the least, an example spectrum obtained, and that raw GABA+/water is estimated by fitting a Gaussian model to compute the area under the curve of the 3ppm GABA peak.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83865-fig7-v1.tif"/></fig></sec><sec id="s4-4"><title>Subset determination</title><p>Each participant visited three times during the study. They completed behavior, fMRI, and MRS sessions on separate days. During the behavior sessions, participants completed several tasks including the NIH cognitive battery of tasks, Rivermead memory and Purdue Pegboard motor tasks. The details about all the tasks completed in the behavior session are described in <xref ref-type="bibr" rid="bib16">Gagnon et al., 2019</xref>. Based on tasks and sessions completed participants were divided into three subsets.</p><p>The first 25 older adults and 20 younger adults enrolled in the study participated in two fMRI sessions (on and off drug) as well as a separate MRS session (described in detail below). They received either 0.5 mg or 1 mg of benzodiazepine during the on-drug fMRI session and the dosage was randomly assigned independent of their age-group, weight, or height. The average days between the two fMRI sessions was 18.72 days (Range 3–79 days), while that between placebo fMRI and spectroscopy session was 16.57 (Range 2–47). The drug-based component of the study was discontinued after the first-year review in February 2018.</p><p>The next subset (subset 2) of 14 older adults and 1 young adult thus only completed an off-drug fMRI and spectroscopy session with average days between two sessions of 10.5 (Range 2–28).</p><p>We later (June 2018) added more behavioral tests specifically targeting the visual perception in noise (described below in detail). Thus, a subset of participants (subset 3) who enrolled in the study after June 2018 completed four visual tasks in noise that are relevant to the current study and described here along with the off-drug fMRI session and spectroscopy session on separate days (See <xref ref-type="table" rid="table3">Table 3</xref> for more details about participant split across sessions and source data file participant demographic details). For subset 3, the average number of days between behavior and fMRI session was 8.92 (Range 1–74), between fMRI and MRS session was 10.14 (Range 1–61), and between behavior and MRS was 19.05 (Range 2–78).</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Participant distribution across three subsets.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Subset</th><th align="left" valign="bottom" rowspan="2">Completed dates</th><th align="left" valign="bottom" colspan="2">Number of participants</th><th align="left" valign="bottom" colspan="2">Age</th><th align="left" valign="bottom" colspan="2">Sex (female counts)</th><th align="left" valign="bottom" colspan="4">Sessions completed</th></tr><tr><th align="left" valign="bottom">Young</th><th align="left" valign="bottom">Older</th><th align="left" valign="bottom">Young</th><th align="left" valign="bottom">Older</th><th align="left" valign="bottom">Young</th><th align="left" valign="bottom">Older</th><th align="left" valign="bottom">fMRI placebo</th><th align="left" valign="bottom">fMRI drug</th><th align="left" valign="bottom">MRS</th><th align="left" valign="bottom">Vis Behav</th></tr></thead><tbody><tr><td align="left" valign="bottom">1</td><td align="left" valign="bottom">February 2018</td><td align="left" valign="bottom">20</td><td align="left" valign="bottom">25</td><td align="left" valign="bottom">23.5</td><td align="left" valign="bottom">69.9</td><td align="left" valign="bottom">13</td><td align="left" valign="bottom">16</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">2</td><td align="left" valign="bottom">June 2018</td><td align="left" valign="bottom">1</td><td align="left" valign="bottom">14</td><td align="left" valign="bottom">21</td><td align="left" valign="bottom">70.9</td><td align="left" valign="bottom">1</td><td align="left" valign="bottom">14</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom"/><td align="left" valign="bottom">✓</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">3</td><td align="left" valign="bottom">March 2020</td><td align="left" valign="bottom">38</td><td align="left" valign="bottom">36</td><td align="left" valign="bottom">22.4</td><td align="left" valign="bottom">69.9</td><td align="left" valign="bottom">15</td><td align="left" valign="bottom">22</td><td align="left" valign="bottom">✓</td><td align="left" valign="bottom"/><td align="left" valign="bottom">✓</td><td align="left" valign="bottom">✓</td></tr></tbody></table></table-wrap></sec><sec id="s4-5"><title>Behavioral testing</title><p>A subset of participants (38 older and 36 younger adults) completed four visual tasks in noise, administered on a Dell laptop with a 15.6-inch screen using the Psychophysics Toolbox. Tasks were completed in a well-lit room where the laptop was placed at a fixed (same and measured for all participants) viewing distance of 21 inches. Participants were instructed to not lean forward or squint when completing the tasks. All tasks consisted of trials in which a 500ms fixation cross was followed by a black and white picture in dynamic Gaussian noise for 500ms followed by a response screen. The next trial began after the response. The order of the stimulus presentation was pseudorandomized but was the same across participants. Each task began with 4 practice trials with feedback and was followed by 50 scored trials without feedback. The tasks followed a staircase procedure – when a participant made three correct responses in a row, the level of noise was increased. Following an incorrect response, the level of noise was decreased. There were a total of 15 levels of Gaussian noise, and each task started at the 5th level of noise. The dependent measure was the average level of noise presented for the last 40 trials. Thus, a higher score represents better performance.</p><list list-type="alpha-lower" id="list3"><list-item><p>Buildings in Noise (BIN)</p><p>The stimulus picture was either a house (50% of trials) or an apartment (50% of trials). Participants were asked to press ‘1’ with their left index finger if they thought the picture was a house and ‘0’ with their right index finger if they thought the picture was an apartment. Stimuli were from <xref ref-type="bibr" rid="bib51">Park et al., 2004</xref>.</p></list-item><list-item><p>Faces in Noise (FIN)</p><p>The stimulus picture was either a male (50% of trials) or female (50% of trials) face. Participants pressed ‘1’ if they thought the picture was a male face and ‘0’ if they thought the picture was a female face. Stimuli were from <xref ref-type="bibr" rid="bib26">Gold et al., 1999</xref>.</p></list-item><list-item><p>Objects in Noise (OIN)</p><p>The stimulus picture was either an office item, such as a stapler (50% of trials), or a food item, such as a hamburger (50% of trials). Participants pressed ‘1’ for an office item and ‘0’ for a food item. Object stimuli were taken from <xref ref-type="bibr" rid="bib4">Brady et al., 2008</xref>.</p></list-item><list-item><p>Scenes in Noise (ScIN)</p><p>The stimulus picture was either an urban (50% of trials) or nature (50% of trial) scene. Participants pressed ‘1’ if they thought the picture was an urban scene and ‘0’ for a nature scene. Scene images were from <xref ref-type="bibr" rid="bib72">Zhou et al., 2018</xref>.</p></list-item></list><p>Using the MATLAB function <italic>factoran</italic> we computed a single visual sensory factor based on these four tasks. The average level of noise presented for the last 40 trials for each of four task was used to do this. The loadings of the tasks on the factor were 0.3 (buildings), 0.8 (faces), 0.5 (objects) and 0.2 (scenes). Since, a higher score on each individual task represents better performance and each loading is positive a higher factor score also reflects better performance. Using principal component analysis (PCA) only one component had an eigenvalue &gt;1, explaining 40% of the variance, and the corresponding weights were 0.53 (buildings), 0.8 (faces), 0.7 (objects), and 0.42 (scenes). The scores on this first component were correlated at (r(72) = 0.88, p&lt;2.2e-16) with the factor scores, we thus present results based on factor score.</p></sec><sec id="s4-6"><title>fMRI session</title><p>MRI data were collected using a 3T General Electric Discovery Magnetic Resonance System with a volumetric quadrature bird cage head coil and two 32-channel receive arrays. A high-resolution T1-weighted structural image was collected using a 3D fast spoiled gradient echo (SPGR) BRAVO pulse sequence with the following parameters: TR = 12.2ms; TE = 5.2ms; TI = 500ms; flip angle = 15°; FOV = 256 × 256 mm; 156 axial slices with thickness = 1 mm and no spacing; acquisition time = 5 min and voxel size (1×1 × 1 mm).</p><p>The functional scan parameters were as follows: T2*-weighted images using a 2D Gradient Echo pulse sequence; Repetition Time (TR)=2000ms; Echo Time (TE)=30ms; flip angle = 90°; Field of View (FOV)=220 x 220 mm; 185 volumes; 43 axial slices; thickness = 3 mm, no spacing; collected in an interleaved bottom-up sequence; and voxel size (3×3 × 3 mm). The total acquisition time for the visual task scan was 6 min 10 s.</p><p>The task consisted of six 20 s blocks of images of male faces and six 20 s blocks of images of houses, presented in a pseudorandomized order and interleaved with twelve 10 s blocks of a fixation cross. Each block consisted of the stimulus presented for 500ms with an interstimulus interval (ISI) of 500ms. The block order was the same for all the participants. This was a passive viewing task but to ensure participant attention, we presented rare target trials once every minute (6 in total). The target trials were images of female faces for the face blocks, and images of apartment buildings for the house blocks. Participants were instructed to press a button with their right index finger every time they saw a target trial. Both age-groups performed well and similarly on correct target hits (Mean hits in young = 4.7 and Mean hits in older adults = 4.9). The fMRI sessions lasted approximately 45 min, including the acquisition of a structural image and other task-based (motor and auditory) and resting state functional data. The remainder of tasks completed in the fMRI session are described in detail in <xref ref-type="bibr" rid="bib16">Gagnon et al., 2019</xref>, of which the motor and visual tasks were counterbalanced in their order of completion across participants and was always done after the structural, resting-state, and auditory scan.</p></sec><sec id="s4-7"><title>MRS session</title><p>Magnetic resonance spectroscopy (MRS) scanning was completed on a different day using the same MRI scanner. This session lasted 1.5 hr, during which we collected another T1-weighted structural image and MRS data. The T1-weighted image was obtained using the same parameters and sequence used during the fMRI session. The MRS data was obtained from 3cm x 3cm x 3 cm voxels placed in the left and right ventrovisual cortex. For each participant, we used their fMRI task sessions to compute an activation map for a face and house viewing vs. fixation contrast. These activation maps provided visual guidance to help with the voxel placement. Specifically, the fMRI technician used the activation maps to place the large MRS voxels so that they were centered roughly at the peak of the activation while not extending outside the brain. The voxels were rotated such that one of the edges was almost parallel and close to the cerebellum-cortical boundary minimizing overlap with dura, parietal, and angular regions. It was also rotated in the inferior-posterior plane to maximize coverage in the posterior occipital regions along with the fusiform and parahippocampal gyrus while minimizing overlap with the hippocampus. Note that these are large voxels, and the primary concern is to minimize overlap with non-cortical regions like ventricles, brainstem, dura, and cortex-cerebellum boundary that affect contamination and good shim (FWHM less than 15) while maximizing the coverage of region of interest. In this case the right and left ventrovisual regions were targeted and the voxel covered parts of fusiform, inferior occipital, calcarine, lingual, and parahippocampal gyrus. It was shifted away from the midline as much as possible without covering the dura. The voxel overlap across participants is shown in <xref ref-type="fig" rid="fig7">Figure 7</xref>. We used a MEGA-PRESS sequence with the following parameters to obtain MR spectra: TE = 68ms (TE1=15ms, TE2=53ms), TR = 1.8 sec, spec. width = 5 kHz, Frequency selective editing pulses (14ms) applied at 1.9ppm (ON) and 7.46 ppm (OFF), 256 transients (128 ON interleaved with 128 OFF) of 4096 data points (See <xref ref-type="table" rid="table4">Table 4</xref> for further details about the scan). For water referencing, eight transients of water unsuppressed data were collected at the end of the sequence, resulting in one reference frame where the NEX = 8 averaging is applied.</p><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>Minimum reporting standard table for MRS session.</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" style="background-color: #E6E6E6;">1. Hardware</th></tr></thead><tbody><tr><td style="background-color: #E6E6E6;">a. Field Strength [T]</td><td align="char" char="." valign="middle">3T</td></tr><tr><td style="background-color: #E6E6E6;">b. Manufacturer</td><td align="left" valign="middle">GE</td></tr><tr><td style="background-color: #E6E6E6;">c. Model (software version if available)</td><td align="left" valign="middle">Discovery MR750 DV26R2</td></tr><tr><td style="background-color: #E6E6E6;">d. RF coils: nuclei (transmit/receive), number of channels, type, body part</td><td align="left" valign="middle">8-channel head coil</td></tr><tr><td style="background-color: #E6E6E6;">e. Additional hardware</td><td align="left" valign="middle">NA</td></tr><tr><th colspan="2" style="background-color: #E6E6E6;">2. Acquisition</th></tr><tr><td style="background-color: #E6E6E6;">a. Pulse sequence</td><td align="left" valign="top">MEGA-PRESS <xref ref-type="bibr" rid="bib44">Mescher et al., 1998</xref></td></tr><tr><td style="background-color: #E6E6E6;">b. Volume of Interest (VOI) locations</td><td align="left" valign="top">Seven VOI collected:<break/><list list-type="bullet" id="list4"><list-item><p>Left primary visual</p></list-item><list-item><p>Left ventral visual</p></list-item><list-item><p>Right ventral visual</p></list-item><list-item><p>Left auditory cortex</p></list-item><list-item><p>Right auditory cortex</p></list-item><list-item><p>Left somatosensory cortex</p></list-item><list-item><p>Right sensorimotor cortex</p></list-item></list>See heatmaps with VOI locations across all participants for relevant visual cortex in <xref ref-type="fig" rid="fig7">Figure 7</xref></td></tr><tr><td style="background-color: #E6E6E6;">c. Nominal VOI size [cm3, mm3]</td><td align="left" valign="top">30x30 x 30 mm<sup>3</sup></td></tr><tr><td style="background-color: #E6E6E6;">d. Repetition time (<italic>T</italic><sub>R</sub>), echo time (<italic>T</italic><sub>E</sub>) [ms, s]</td><td align="left" valign="top"><italic>T</italic><sub>R</sub> = 1800ms, <italic>T</italic><sub>E</sub> = 68ms<break/>(<italic>T</italic><sub>E</sub>1 = 15ms, <italic>T</italic><sub>E</sub><sup>2</sup> = 53ms)</td></tr><tr><td style="background-color: #E6E6E6;">e. Total number of excitations of or acquisitions per spectrum<break/>In time series for kinetic studies<break/>i. Number of averaged spectra (NA) per time point<break/>ii. Averaging method (eg block-wise or moving average)<break/>iii. Total number of spectra (acquired/in time series)</td><td align="left" valign="top">256 (128 ON interleaved with 128 OFF)</td></tr><tr><td style="background-color: #E6E6E6;">f. Additional sequence parameters (spectral width in Hz, number of spectral points, frequency offsets) If STEAM: mixing time (<italic>T</italic><sub>M</sub>) If MRSI: 2D or 3D, FOX in all directions, matrix size, acceleration factors, sampling method</td><td align="left" valign="top">Spectral width = 5 kHz<break/>Data points = 4,096<break/>Frequency selective editing pulses applied at:<break/>ON pulse = 1.9 ppm<break/>OFF pulse = 7.46 ppm</td></tr><tr><td style="background-color: #E6E6E6;">g. Water suppression method</td><td align="left" valign="top">CHESS</td></tr><tr><td style="background-color: #E6E6E6;">h. Shimming method, reference peak, and thresholds for “acceptance of shim” chosen</td><td align="left" valign="top">Auto-shim, if linewidth &gt;15 then voxel placement adjusted and shim redone.</td></tr><tr><td style="background-color: #E6E6E6;">i. Triggering or motion correction method (respiratory, peripheral, cardiac triggering, incl. device used and delays)</td><td align="left" valign="top">None</td></tr><tr><th colspan="2" style="background-color: #E6E6E6;">3. Data analysis methods and outputs</th></tr><tr><td style="background-color: #E6E6E6;">a. Analysis software</td><td align="left" valign="top">Gannet 3.1 in MATLAB</td></tr><tr><td style="background-color: #E6E6E6;">b. Processing steps deviating from quoted reference or product</td><td align="left" valign="top">No deviations – standard steps were used.</td></tr><tr><td style="background-color: #E6E6E6;">c. Output measure (eg absolute concentration, institutional units, ratio), processing steps deviating from quote reference or product</td><td align="left" valign="top"><bold>Gannet outputs:</bold><break/>- Ratio to Cr (GABA/Cr)<break/>- Ratio to NAA (GABA/NAA)<break/>- Institutional units relative to water, uncorrected for VOI tissue composition (GABA/H<sub>2</sub>O)<break/>- Institutional units relative to water, corrected for VOI CSF content (GABA/H<sub>2</sub>O CSF)<break/>- Institutional units relative to water, corrected for tissue composition of VOI (GABA/H<sub>2</sub>O TC)<break/>- Institutional units relative to water, corrected for tissue composition of VOI, and alpha of.5 applied to white matter % (GABA/H<sub>2</sub>O ATC)<break/>- Institutional units relative to water, corrected for tissue composition of VOI, and alpha of.5 applied to white matter %, and normallised to average tissue composition of VOI in young adults (GABA/H<sub>2</sub>O GATC)</td></tr><tr><td style="background-color: #E6E6E6;">d. Quantification references and assumptions, fitting model assumption</td><td align="left" valign="top"> </td></tr><tr><th colspan="2" style="background-color: #E6E6E6;">4. Data quality</th></tr><tr><td style="background-color: #E6E6E6;">a. Reported variables</td><td align="left" valign="top">GABA +fit error</td></tr><tr><td style="background-color: #E6E6E6;">b. Data exclusion criteria</td><td align="left" valign="top">- Spectra were visually inspected for GABA peaks and model fits.<break/>- Gannet derived estimates were included in analyses if GABA +fit error was below 15%</td></tr><tr><td style="background-color: #E6E6E6;">c. Quality measures of post-processing model fitting <break/>(eg CRLB, goodness of fit, SD of residual)</td><td align="left" valign="top"><bold>Gannet:</bold> Fit Error %</td></tr><tr><th colspan="2" style="background-color: #E6E6E6;">5. Average Spectra</th></tr><tr><td style="background-color: #E6E6E6;">Within Older Adults with ±1 Standard deviation<inline-graphic mimetype="image" mime-subtype="tif" xlink:href="elife-83865-inf001-v1.tif"/></td><td align="left" valign="top">Within Younger Adults with ±1 Standard deviation<inline-graphic mimetype="image" mime-subtype="tif" xlink:href="elife-83865-inf002-v1.tif"/></td></tr></tbody></table></table-wrap></sec><sec id="s4-8"><title>Drug session</title><p>A subset of participants (20 young and 25 older adults) underwent two functional MRI sessions instead of one, one after taking a low dose benzodiazepine (lorazepam) and one after taking a placebo pill. The functional scanning parameters were identical to those described above. The pills were given approximately 1 hr before the session and the order of the sessions (on and off drug) was counterbalanced across participants. During the drug session, participants were administered a 0.5 or 1 mg oral dose of lorazepam (a benzodiazepine). The dosage was assigned randomly across participants independent of all other factors. Participants were not told which pill they received on which day (they were blind to the drug administration order) but the experimenter was not.</p></sec><sec id="s4-9"><title>fMRI data preprocessing</title><p>The fMRI data were preprocessed and analyzed using a combination of FMRIB Software Library (FSL), SPM12 and MATLAB-based scripts. The first 5 volumes of each scan were discarded. Heart rate was collected via a pulse oximeter placed on the left middle finger and the data was physio corrected during preprocessing. We performed first-level preprocessing using FSL-FEAT <xref ref-type="bibr" rid="bib70">Woolrich et al., 2001</xref> with default parameters for motion correction and normalization. Spatial smoothing with a 7 mm full-width at half maximum Gaussian kernel was performed. We used the SPM12 function ‘spm detrend’ to remove linear, quadratic and cubic trends in the time series and also applied a Butterworth filter (0.01–0.1 Hz). We then ran FSL MELODIC to perform Independent Component Analysis (ICA). Three separate raters identified noise components through manual visual inspection <xref ref-type="bibr" rid="bib34">Kelly et al., 2010</xref>. These components reflected noise related to sinus activity, vascular and ventricle activations, and motion. We then removed the components identified as noise by at least two of the three raters using the FSL regfilt function. Subsequently, we performed linear registration of the functional and anatomical images of each participant and the MNI152 template using the FSL FLIRT function.</p></sec><sec id="s4-10"><title>Quantification of brain signal variability (SD<sub>BOLD</sub>)</title><p>After preprocessing the fMRI data, we normalized all blocks for each condition (houses and faces separately) such that the overall 4D mean across brain and the block was the same. Then, for each voxel, we subtracted the block mean and concatenated the time-series across all blocks for that condition. The standard deviation in this time-series during each of the conditions (faces and houses) was computed at each voxel for each participant (similar to previous work <xref ref-type="bibr" rid="bib24">Garrett et al., 2020</xref>). Modulation of variability (<inline-formula><mml:math id="inf87"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) was computed as the difference between the two conditions (SD<sub>BOLD-HOUSES</sub> – SD<sub>BOLD-FACES</sub>) at each of the voxels in a grey matter volume mask. Similarly, <inline-formula><mml:math id="inf88"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> on drug was computed for the subset of participants who were administered lorazepam.</p></sec><sec id="s4-11"><title>Quantification of GABA levels</title><p>We used Gannet 3.0 (<xref ref-type="bibr" rid="bib14">Edden et al., 2014</xref>), a MATLAB based toolbox, to estimate GABA+/Water levels based on the MEGA-PRESS difference spectra in each of the MRS voxels. All the time-domain data were phase corrected and frequency corrected using spectral registration and filtered with 3 Hz exponential line broadening and zero-filled by a factor of 16. The GABA levels were scaled to water and expressed in institutional units by Gannet. Gannet quantifies GABA levels by fitting a five-parameter Gaussian model to the MR spectrum between 2.19 and 3.55 ppm while the water peak is modelled using a Gaussian-Lorentzian function. The MEGA-PRESS editing scheme also results in excitation of coedited macromolecules (MM), which can contribute up to 45% to the edited signal around 3ppm overlapping with the GABA peak. Thus, all GABA values are reported as GABA+ (i.e. GABA +MM) in the present study.</p><p>Gannet’s integrated voxel-to-image co-registration procedure produces a binary mask of the MRS voxel. Using an SPM-based segmentation function, Gannet estimates the tissue composition (voxel fractions containing Cerebrospinal Fluid (CSF), Grey Matter (GM) and White Matter (WM)). Gannet then estimates a tissue-corrected GABA +value that accounts for the fraction of grey matter, white matter, and CSF in each MRS voxel as well as the differential relaxation constants and water visibility in the different tissue types (<xref ref-type="bibr" rid="bib29">Harris et al., 2015</xref>). Based on a quality control check of the spectra (flagged if the value was more than 3 standard deviations from mean, the fit error was greater than 10% for water, or the CSF fraction was more than 20%), we flagged and discarded three right and seven left GABA values. GABA measures between right and left ventrovisual voxel were correlated at r(134) = 0.57 (p&lt;0.0001). Thus, we computed an average GABA +measure for each participant. One young participant had both right and left ventrovisual GABA values flagged and was excluded from the analysis.</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>To estimate the effects of task-condition on SD<sub>BOLD</sub> and the effect of age and GABA on <inline-formula><mml:math id="inf89"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> we employed multivariate partial least squares (PLS) analyses (<xref ref-type="bibr" rid="bib43">McIntosh et al., 1996</xref>).</p><p>1) To estimate the effects of task-condition on SD<sub>BOLD</sub> we used a task-PLS. In this method, first a between-subject covariance (COV) matrix is computed between house and face conditions and each voxel’s SD<sub>BOLD</sub>. Then a left singular vector of experimental condition weights (U) is estimated, along with a right singular vector of brain voxel weights (V) and a diagonal matrix of singular values (S). Significance of the detected relations is assessed using 1000 permutation tests of the singular value corresponding to each latent variable (LV). This resulted in two LVs of which only one was significant and represented greater variability during the house condition than during the face condition. <italic>Brainscore</italic> was computed separately for each condition as the dot product of brain voxel weights and each subjects’ SD<sub>BOLD-HOUSES</sub> and SD<sub>BOLD-FACES</sub>.</p><p>2) We employed rank-based Behavior-PLS for investigating the effects of age and GABA levels on <inline-formula><mml:math id="inf90"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> in a visual anatomical mask within our sample of 134 subjects (after excluding the one subject whose GABA estimates were flagged). The visual anatomical mask is a broad mask that contained the occipital pole, lingual gyrus, inferior division of lateral occipital cortex, the temporooccipital part of the inferior and middle temporal gyrus, temporal occipital fusiform cortex, occipital fusiform gyrus, and parahippocampal gyrus from the Harvard-Oxford atlas in FSL. A between-subject correlation matrix (CORR) was computed between each voxel’s <inline-formula><mml:math id="inf91"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (i.e. SD<sub>BOLD-HOUSES</sub> – SD<sub>BOLD-FACES</sub>) within this mask and both – (1) MRS-based average ventrovisual GABA measures and (2) self-reported age (in years). Then, CORR was decomposed using singular value decomposition (SVD). This decomposition produced a matrix of behavior weights (U), a matrix of brain voxel weights (V), and a diagonal matrix of singular values (S). A single significant latent variable captured the activity pattern depicting the brain regions that show the strongest relationship of <inline-formula><mml:math id="inf92"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> with both age and GABA. The behavior weights (U) of this LV suggest lower GABA levels and greater age were associated with lower <inline-formula><mml:math id="inf93"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>. We obtained a summary measure of each participant’s expression of this LV’s spatial pattern (a within-person “<italic>Brainscore</italic>”) by taking a dot product of the brain weights (V) with <inline-formula><mml:math id="inf94"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> on placebo (and on drug for the subset that received the manipulation). This <italic>Brainscore</italic> was also used for investigating the role of <inline-formula><mml:math id="inf95"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> on visual discrimination task.</p><p>In both models, we used a bootstrapping procedure (1000 bootstrapped resamples) to reveal the robustness of voxel weights. By dividing each voxel’s weight by its bootstrapped standard error, we obtained ‘bootstrap ratios’ (BSRs) as estimates of robustness. We thresholded BSRs at values of ±3.00 (~99.9% confidence interval). Statistical analyses were conducted using R (<xref ref-type="bibr" rid="bib56">R Development Core Team, 2013</xref>). Figures were plotted using the ggplot2 package (<xref ref-type="bibr" rid="bib69">Wickham, 2016</xref>) and the lme4 package (<xref ref-type="bibr" rid="bib3">Bates et al., 2007</xref>) was used to perform the linear mixed effects analysis. We used a Cook’s Distance greater than 4/sample size to flag and remove outliers from each of mixed effects models reported in the results.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Supervision, Methodology, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Informed consent was obtained from all participants in the study. The ethical approval for the study was granted by the Institutional Review Board of The University of Michigan (HUM00103117).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-83865-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>De-identified processed data for all participants.</title></caption><media xlink:href="elife-83865-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Since, the raw MRI, MRS and fMRI data used in the current manuscript are collected as a part of a larger (MIND) study they will be made publicly available only on completion of the main study (estimated: 2027 based on the umbrella policies applicable for the larger study). Before that, data can be requested via email correspondence for research purposes. For data transparency and reproducibility, an Excel-sheet with all the de-identified values to reproduce all figures and results has been included as <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. The processing Matlab code is based on previous work and available on <ext-link ext-link-type="uri" xlink:href="https://github.com/umich-tpolk-lab/DynamicRecoveryPaper">GitHub</ext-link> (<xref ref-type="bibr" rid="bib65">umich-tpolk-lab, 2021</xref>).</p></sec><ack id="ack"><title>Acknowledgements</title><p>HHS | NIH | National Institute on Aging (NIA): Poortata Lalwani, AG068517; HHS | NIH | National Institute on Aging (NIA): Thad Polk, AG050523 The funders had no role in study design, data colection and interpretation, or the decision to submit the work for publication.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>V</given-names></name><name><surname>Cowley</surname><given-names>AB</given-names></name><name><surname>Alfaori</surname><given-names>Q</given-names></name><name><surname>Larremore</surname><given-names>DB</given-names></name><name><surname>Restrepo</surname><given-names>JG</given-names></name><name><surname>Shew</surname><given-names>WL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Robust entropy requires strong and balanced excitatory and inhibitory synapses</article-title><source>Chaos</source><volume>28</volume><elocation-id>e103115</elocation-id><pub-id pub-id-type="doi">10.1063/1.5043429</pub-id><pub-id pub-id-type="pmid">30384653</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäckman</surname><given-names>L</given-names></name><name><surname>Nyberg</surname><given-names>L</given-names></name><name><surname>Lindenberger</surname><given-names>U</given-names></name><name><surname>Li</surname><given-names>SC</given-names></name><name><surname>Farde</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The correlative triad among aging, dopamine, and cognition: current status and future prospects</article-title><source>Neuroscience &amp; Biobehavioral Reviews</source><volume>30</volume><fpage>791</fpage><lpage>807</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2006.06.005</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>D</given-names></name><name><surname>Sarkar</surname><given-names>D</given-names></name><name><surname>Bates</surname><given-names>MD</given-names></name><name><surname>Matrix</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><data-title>The lme4 package</data-title><version designator="Version 2">Version 2</version><source>R Package</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/lme4/index.html">https://cran.r-project.org/web/packages/lme4/index.html</ext-link></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>TF</given-names></name><name><surname>Konkle</surname><given-names>T</given-names></name><name><surname>Alvarez</surname><given-names>GA</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Visual long-term memory has a massive storage capacity for object details</article-title><source>PNAS</source><volume>105</volume><fpage>14325</fpage><lpage>14329</lpage><pub-id pub-id-type="doi">10.1073/pnas.0803390105</pub-id><pub-id pub-id-type="pmid">18787113</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruffaerts</surname><given-names>R</given-names></name><name><surname>Tyler</surname><given-names>LK</given-names></name><name><surname>Shafto</surname><given-names>M</given-names></name><name><surname>Tsvetanov</surname><given-names>KA</given-names></name><collab>Cambridge Centre for Ageing and Neuroscience</collab><name><surname>Clarke</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Perceptual and conceptual processing of visual objects across the adult lifespan</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>13771</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-50254-5</pub-id><pub-id pub-id-type="pmid">31551468</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo-Flores Guzmán</surname><given-names>B</given-names></name><name><surname>Vinnakota</surname><given-names>C</given-names></name><name><surname>Govindpani</surname><given-names>K</given-names></name><name><surname>Waldvogel</surname><given-names>HJ</given-names></name><name><surname>Faull</surname><given-names>RLM</given-names></name><name><surname>Kwakowsky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The GABAergic system as a therapeutic target for Alzheimer’s disease</article-title><source>Journal of Neurochemistry</source><volume>146</volume><fpage>649</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1111/jnc.14345</pub-id><pub-id pub-id-type="pmid">29645219</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carson</surname><given-names>N</given-names></name><name><surname>Leach</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A re-examination of montreal cognitive assessment (moca) cutoff scores</article-title><source>International Journal of Geriatric Psychiatry</source><volume>33</volume><fpage>379</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1002/gps.4756</pub-id><pub-id pub-id-type="pmid">28731508</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassady</surname><given-names>K</given-names></name><name><surname>Gagnon</surname><given-names>H</given-names></name><name><surname>Lalwani</surname><given-names>P</given-names></name><name><surname>Simmonite</surname><given-names>M</given-names></name><name><surname>Foerster</surname><given-names>B</given-names></name><name><surname>Park</surname><given-names>D</given-names></name><name><surname>Peltier</surname><given-names>SJ</given-names></name><name><surname>Petrou</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>SF</given-names></name><name><surname>Weissman</surname><given-names>DH</given-names></name><name><surname>Seidler</surname><given-names>RD</given-names></name><name><surname>Polk</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Sensorimotor network segregation declines with age and is linked to GABA and to sensorimotor performance</article-title><source>NeuroImage</source><volume>186</volume><fpage>234</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2018.11.008</pub-id><pub-id pub-id-type="pmid">30414983</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalavi</surname><given-names>S</given-names></name><name><surname>Pauwels</surname><given-names>L</given-names></name><name><surname>Heise</surname><given-names>KF</given-names></name><name><surname>Zivari Adab</surname><given-names>H</given-names></name><name><surname>Maes</surname><given-names>C</given-names></name><name><surname>Puts</surname><given-names>NAJ</given-names></name><name><surname>Edden</surname><given-names>RAE</given-names></name><name><surname>Swinnen</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The neurochemical basis of the contextual interference effect</article-title><source>Neurobiology of Aging</source><volume>66</volume><fpage>85</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.02.014</pub-id><pub-id pub-id-type="pmid">29549874</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname><given-names>JD</given-names></name><name><surname>Gagnon</surname><given-names>H</given-names></name><name><surname>Lalwani</surname><given-names>P</given-names></name><name><surname>Cassady</surname><given-names>KE</given-names></name><name><surname>Simmonite</surname><given-names>M</given-names></name><name><surname>Seidler</surname><given-names>RD</given-names></name><name><surname>Taylor</surname><given-names>SF</given-names></name><name><surname>Weissman</surname><given-names>DH</given-names></name><name><surname>Park</surname><given-names>DC</given-names></name><name><surname>Polk</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>GABA levels in ventral visual cortex decline with age and are associated with neural distinctiveness</article-title><source>Neurobiology of Aging</source><volume>102</volume><fpage>170</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2021.02.013</pub-id><pub-id pub-id-type="pmid">33770531</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cools</surname><given-names>R</given-names></name><name><surname>Frank</surname><given-names>MJ</given-names></name><name><surname>Gibbs</surname><given-names>SE</given-names></name><name><surname>Miyakawa</surname><given-names>A</given-names></name><name><surname>Jagust</surname><given-names>W</given-names></name><name><surname>D’Esposito</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>1538</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4467-08.2009</pub-id><pub-id pub-id-type="pmid">19193900</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuypers</surname><given-names>K</given-names></name><name><surname>Maes</surname><given-names>C</given-names></name><name><surname>Swinnen</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Aging and GABA</article-title><source>Aging</source><volume>10</volume><fpage>1186</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.18632/aging.101480</pub-id><pub-id pub-id-type="pmid">29905530</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobri</surname><given-names>SGJ</given-names></name><name><surname>Ross</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Total GABA level in human auditory cortex is associated with speech-in-noise understanding in older age</article-title><source>NeuroImage</source><volume>225</volume><elocation-id>117474</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2020.117474</pub-id><pub-id pub-id-type="pmid">33099004</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edden</surname><given-names>RAE</given-names></name><name><surname>Puts</surname><given-names>NAJ</given-names></name><name><surname>Harris</surname><given-names>AD</given-names></name><name><surname>Barker</surname><given-names>PB</given-names></name><name><surname>Evans</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra</article-title><source>Journal of Magnetic Resonance Imaging</source><volume>40</volume><fpage>1445</fpage><lpage>1452</lpage><pub-id pub-id-type="doi">10.1002/jmri.24478</pub-id><pub-id pub-id-type="pmid">25548816</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagiolini</surname><given-names>M</given-names></name><name><surname>Fritschy</surname><given-names>JM</given-names></name><name><surname>Löw</surname><given-names>K</given-names></name><name><surname>Möhler</surname><given-names>H</given-names></name><name><surname>Rudolph</surname><given-names>U</given-names></name><name><surname>Hensch</surname><given-names>TK</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Specific GABAA circuits for visual cortical plasticity</article-title><source>Science</source><volume>303</volume><fpage>1681</fpage><lpage>1683</lpage><pub-id pub-id-type="doi">10.1126/science.1091032</pub-id><pub-id pub-id-type="pmid">15017002</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname><given-names>H</given-names></name><name><surname>Simmonite</surname><given-names>M</given-names></name><name><surname>Cassady</surname><given-names>K</given-names></name><name><surname>Chamberlain</surname><given-names>J</given-names></name><name><surname>Freiburger</surname><given-names>E</given-names></name><name><surname>Lalwani</surname><given-names>P</given-names></name><name><surname>Kelley</surname><given-names>S</given-names></name><name><surname>Foerster</surname><given-names>B</given-names></name><name><surname>Park</surname><given-names>DC</given-names></name><name><surname>Petrou</surname><given-names>M</given-names></name><name><surname>Seidler</surname><given-names>RD</given-names></name><name><surname>Taylor</surname><given-names>SF</given-names></name><name><surname>Weissman</surname><given-names>DH</given-names></name><name><surname>Polk</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Michigan Neural Distinctiveness (MiND) study protocol: investigating the scope, causes, and consequences of age-related neural dedifferentiation</article-title><source>BMC Neurology</source><volume>19</volume><elocation-id>61</elocation-id><pub-id pub-id-type="doi">10.1186/s12883-019-1294-6</pub-id><pub-id pub-id-type="pmid">30979359</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Edden</surname><given-names>RAE</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Puts</surname><given-names>NAJ</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Barker</surname><given-names>PB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels</article-title><source>NeuroImage</source><volume>78</volume><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.04.012</pub-id><pub-id pub-id-type="pmid">23587685</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Ren</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Edden</surname><given-names>RAE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Decreased auditory GABA+ concentrations in presbycusis demonstrated by edited magnetic resonance spectroscopy</article-title><source>NeuroImage</source><volume>106</volume><fpage>311</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2014.11.023</pub-id><pub-id pub-id-type="pmid">25463460</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Kovacevic</surname><given-names>N</given-names></name><name><surname>McIntosh</surname><given-names>AR</given-names></name><name><surname>Grady</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Blood oxygen level-dependent signal variability is more than just noise</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>4914</fpage><lpage>4921</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5166-09.2010</pub-id><pub-id pub-id-type="pmid">20371811</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Kovacevic</surname><given-names>N</given-names></name><name><surname>McIntosh</surname><given-names>AR</given-names></name><name><surname>Grady</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The importance of being variable</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>4496</fpage><lpage>4503</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5641-10.2011</pub-id><pub-id pub-id-type="pmid">21430150</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Kovacevic</surname><given-names>N</given-names></name><name><surname>McIntosh</surname><given-names>AR</given-names></name><name><surname>Grady</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>The modulation of BOLD variability between cognitive states varies by age and processing speed</article-title><source>Cerebral Cortex</source><volume>23</volume><fpage>684</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhs055</pub-id><pub-id pub-id-type="pmid">22419679</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Samanez-Larkin</surname><given-names>GR</given-names></name><name><surname>MacDonald</surname><given-names>SWS</given-names></name><name><surname>Lindenberger</surname><given-names>U</given-names></name><name><surname>McIntosh</surname><given-names>AR</given-names></name><name><surname>Grady</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>Moment-to-moment brain signal variability: a next frontier in human brain mapping?</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>37</volume><fpage>610</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.02.015</pub-id><pub-id pub-id-type="pmid">23458776</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Nagel</surname><given-names>IE</given-names></name><name><surname>Preuschhof</surname><given-names>C</given-names></name><name><surname>Burzynska</surname><given-names>AZ</given-names></name><name><surname>Marchner</surname><given-names>J</given-names></name><name><surname>Wiegert</surname><given-names>S</given-names></name><name><surname>Jungehülsing</surname><given-names>GJ</given-names></name><name><surname>Nyberg</surname><given-names>L</given-names></name><name><surname>Villringer</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>SC</given-names></name><name><surname>Heekeren</surname><given-names>HR</given-names></name><name><surname>Bäckman</surname><given-names>L</given-names></name><name><surname>Lindenberger</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Amphetamine modulates brain signal variability and working memory in younger and older adults</article-title><source>PNAS</source><volume>112</volume><fpage>7593</fpage><lpage>7598</lpage><pub-id pub-id-type="doi">10.1073/pnas.1504090112</pub-id><pub-id pub-id-type="pmid">26034283</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Epp</surname><given-names>SM</given-names></name><name><surname>Kleemeyer</surname><given-names>M</given-names></name><name><surname>Lindenberger</surname><given-names>U</given-names></name><name><surname>Polk</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Higher performers upregulate brain signal variability in response to more feature-rich visual input</article-title><source>NeuroImage</source><volume>217</volume><elocation-id>116836</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2020.116836</pub-id><pub-id pub-id-type="pmid">32283277</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Kloosterman</surname><given-names>NA</given-names></name><name><surname>Epp</surname><given-names>S</given-names></name><name><surname>Chopurian</surname><given-names>V</given-names></name><name><surname>Kosciessa</surname><given-names>JQ</given-names></name><name><surname>Waschke</surname><given-names>L</given-names></name><name><surname>Skowron</surname><given-names>A</given-names></name><name><surname>Shine</surname><given-names>J</given-names></name><name><surname>Perry</surname><given-names>A</given-names></name><name><surname>Salami</surname><given-names>A</given-names></name><name><surname>Rieckmann</surname><given-names>A</given-names></name><name><surname>Papenberg</surname><given-names>G</given-names></name><name><surname>Wåhlin</surname><given-names>A</given-names></name><name><surname>Karalija</surname><given-names>N</given-names></name><name><surname>Andersson</surname><given-names>M</given-names></name><name><surname>Riklund</surname><given-names>K</given-names></name><name><surname>Lövdén</surname><given-names>M</given-names></name><name><surname>Bäckman</surname><given-names>L</given-names></name><name><surname>Nyberg</surname><given-names>L</given-names></name><name><surname>Lindenberger</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Dynamic regulation of neural variability during working memory reflects dopamine, functional integration, and decision-making</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.05.05.490687</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>J</given-names></name><name><surname>Bennett</surname><given-names>PJ</given-names></name><name><surname>Sekuler</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Signal but not noise changes with perceptual learning</article-title><source>Nature</source><volume>402</volume><fpage>176</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1038/46027</pub-id><pub-id pub-id-type="pmid">10647007</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grady</surname><given-names>CL</given-names></name><name><surname>Garrett</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Understanding variability in the BOLD signal and why it matters for aging</article-title><source>Brain Imaging and Behavior</source><volume>8</volume><fpage>274</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1007/s11682-013-9253-0</pub-id><pub-id pub-id-type="pmid">24008589</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grady</surname><given-names>CL</given-names></name><name><surname>Garrett</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Brain signal variability is modulated as a function of internal and external demand in younger and older adults</article-title><source>NeuroImage</source><volume>169</volume><fpage>510</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.12.031</pub-id><pub-id pub-id-type="pmid">29253658</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>AD</given-names></name><name><surname>Puts</surname><given-names>NAJ</given-names></name><name><surname>Edden</surname><given-names>RAE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Tissue correction for GABA-edited MRS: considerations of voxel composition, tissue segmentation, and tissue relaxations</article-title><source>Journal of Magnetic Resonance Imaging</source><volume>42</volume><fpage>1431</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1002/jmri.24903</pub-id><pub-id pub-id-type="pmid">26172043</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensch</surname><given-names>TK</given-names></name><name><surname>Fagiolini</surname><given-names>M</given-names></name><name><surname>Mataga</surname><given-names>N</given-names></name><name><surname>Stryker</surname><given-names>MP</given-names></name><name><surname>Baekkeskov</surname><given-names>S</given-names></name><name><surname>Kash</surname><given-names>SF</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Local GABA circuit control of experience-dependent plasticity in developing visual cortex</article-title><source>Science</source><volume>282</volume><fpage>1504</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1126/science.282.5393.1504</pub-id><pub-id pub-id-type="pmid">9822384</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermans</surname><given-names>L</given-names></name><name><surname>Levin</surname><given-names>O</given-names></name><name><surname>Maes</surname><given-names>C</given-names></name><name><surname>van Ruitenbeek</surname><given-names>P</given-names></name><name><surname>Heise</surname><given-names>KF</given-names></name><name><surname>Edden</surname><given-names>RAE</given-names></name><name><surname>Puts</surname><given-names>NAJ</given-names></name><name><surname>Peeters</surname><given-names>R</given-names></name><name><surname>King</surname><given-names>BR</given-names></name><name><surname>Meesen</surname><given-names>RLJ</given-names></name><name><surname>Leunissen</surname><given-names>I</given-names></name><name><surname>Swinnen</surname><given-names>SP</given-names></name><name><surname>Cuypers</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>GABA levels and measures of intracortical and interhemispheric excitability in healthy young and older adults: an MRS-TMS study</article-title><source>Neurobiology of Aging</source><volume>65</volume><fpage>168</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.01.023</pub-id><pub-id pub-id-type="pmid">29494863</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermundstad</surname><given-names>AM</given-names></name><name><surname>Briguglio</surname><given-names>JJ</given-names></name><name><surname>Conte</surname><given-names>MM</given-names></name><name><surname>Victor</surname><given-names>JD</given-names></name><name><surname>Balasubramanian</surname><given-names>V</given-names></name><name><surname>Tkačik</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Variance predicts salience in central sensory processing</article-title><source>eLife</source><volume>3</volume><elocation-id>e03722</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.03722</pub-id><pub-id pub-id-type="pmid">25396297</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>EG</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>GABAergic neurons and their role in cortical plasticity in primates</article-title><source>Cerebral Cortex</source><volume>3</volume><fpage>361</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1093/cercor/3.5.361-a</pub-id><pub-id pub-id-type="pmid">8260806</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>RE</given-names><suffix>Jr</suffix></name><name><surname>Alexopoulos</surname><given-names>GS</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Gunning</surname><given-names>FM</given-names></name><name><surname>Murphy</surname><given-names>CF</given-names></name><name><surname>Morimoto</surname><given-names>SS</given-names></name><name><surname>Kanellopoulos</surname><given-names>D</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name><name><surname>Lim</surname><given-names>KO</given-names></name><name><surname>Hoptman</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Visual inspection of independent components: defining a procedure for artifact removal from fMRI data</article-title><source>Journal of Neuroscience Methods</source><volume>189</volume><fpage>233</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2010.03.028</pub-id><pub-id pub-id-type="pmid">20381530</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>LJ</given-names></name><name><surname>McIntosh</surname><given-names>AR</given-names></name><name><surname>Abdi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Partial Least Squares (PLS) methods for neuroimaging: a tutorial and review</article-title><source>NeuroImage</source><volume>56</volume><fpage>455</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.07.034</pub-id><pub-id pub-id-type="pmid">20656037</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krohn</surname><given-names>S</given-names></name><name><surname>von Schwanenflug</surname><given-names>N</given-names></name><name><surname>Waschke</surname><given-names>L</given-names></name><name><surname>Romanello</surname><given-names>A</given-names></name><name><surname>Gell</surname><given-names>M</given-names></name><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Finke</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A spatiotemporal complexity architecture of human brain activity</article-title><source>Science Advances</source><volume>9</volume><elocation-id>eabq3851</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abq3851</pub-id><pub-id pub-id-type="pmid">36724223</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurcyus</surname><given-names>K</given-names></name><name><surname>Annac</surname><given-names>E</given-names></name><name><surname>Hanning</surname><given-names>NM</given-names></name><name><surname>Harris</surname><given-names>AD</given-names></name><name><surname>Oeltzschner</surname><given-names>G</given-names></name><name><surname>Edden</surname><given-names>R</given-names></name><name><surname>Riedl</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Opposite dynamics of GABA and glutamate levels in the occipital cortex during visual processing</article-title><source>The Journal of Neuroscience</source><volume>38</volume><fpage>9967</fpage><lpage>9976</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1214-18.2018</pub-id><pub-id pub-id-type="pmid">30282724</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalwani</surname><given-names>P</given-names></name><name><surname>Gagnon</surname><given-names>H</given-names></name><name><surname>Cassady</surname><given-names>K</given-names></name><name><surname>Simmonite</surname><given-names>M</given-names></name><name><surname>Peltier</surname><given-names>S</given-names></name><name><surname>Seidler</surname><given-names>RD</given-names></name><name><surname>Taylor</surname><given-names>SF</given-names></name><name><surname>Weissman</surname><given-names>DH</given-names></name><name><surname>Polk</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neural distinctiveness declines with age in auditory cortex and is associated with auditory GABA levels</article-title><source>NeuroImage</source><volume>201</volume><elocation-id>116033</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2019.116033</pub-id><pub-id pub-id-type="pmid">31326572</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalwani</surname><given-names>P</given-names></name><name><surname>Garrett</surname><given-names>DD</given-names></name><name><surname>Polk</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dynamic recovery: GABA agonism restores neural variability in older, poorer performing adults</article-title><source>The Journal of Neuroscience</source><volume>41</volume><fpage>9350</fpage><lpage>9360</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0335-21.2021</pub-id><pub-id pub-id-type="pmid">34732523</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leventhal</surname><given-names>AG</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Pu</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>GABA and its agonists improved visual cortical function in senescent monkeys</article-title><source>Science</source><volume>300</volume><fpage>812</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1126/science.1082874</pub-id><pub-id pub-id-type="pmid">12730605</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>O</given-names></name><name><surname>Weerasekera</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>BR</given-names></name><name><surname>Heise</surname><given-names>KF</given-names></name><name><surname>Sima</surname><given-names>DM</given-names></name><name><surname>Chalavi</surname><given-names>S</given-names></name><name><surname>Maes</surname><given-names>C</given-names></name><name><surname>Peeters</surname><given-names>R</given-names></name><name><surname>Sunaert</surname><given-names>S</given-names></name><name><surname>Cuypers</surname><given-names>K</given-names></name><name><surname>Van Huffel</surname><given-names>S</given-names></name><name><surname>Mantini</surname><given-names>D</given-names></name><name><surname>Himmelreich</surname><given-names>U</given-names></name><name><surname>Swinnen</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Sensorimotor cortex neurometabolite levels as correlate of motor performance in normal aging: evidence from a <sup>1</sup>H-MRS study</article-title><source>NeuroImage</source><volume>202</volume><elocation-id>116050</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuroimage.2019.116050</pub-id><pub-id pub-id-type="pmid">31349070</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzen</surname><given-names>SE</given-names></name><name><surname>DeDeo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The evolution of lossy compression</article-title><source>Journal of the Royal Society, Interface</source><volume>14</volume><elocation-id>20170166</elocation-id><pub-id pub-id-type="doi">10.1098/rsif.2017.0166</pub-id><pub-id pub-id-type="pmid">28490604</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname><given-names>AR</given-names></name><name><surname>Bookstein</surname><given-names>FL</given-names></name><name><surname>Haxby</surname><given-names>JV</given-names></name><name><surname>Grady</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Spatial pattern analysis of functional brain images using partial least squares</article-title><source>NeuroImage</source><volume>3</volume><fpage>143</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1006/nimg.1996.0016</pub-id><pub-id pub-id-type="pmid">9345485</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mescher</surname><given-names>M</given-names></name><name><surname>Merkle</surname><given-names>H</given-names></name><name><surname>Kirsch</surname><given-names>J</given-names></name><name><surname>Garwood</surname><given-names>M</given-names></name><name><surname>Gruetter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Simultaneous in vivo spectral editing and water suppression</article-title><source>NMR in Biomedicine</source><volume>11</volume><fpage>266</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1492(199810)11:6&lt;266::AID-NBM530&gt;3.3.CO;2-A</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millar</surname><given-names>PR</given-names></name><name><surname>Ances</surname><given-names>BM</given-names></name><name><surname>Gordon</surname><given-names>BA</given-names></name><name><surname>Benzinger</surname><given-names>TLS</given-names></name><name><surname>Fagan</surname><given-names>AM</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Balota</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer’s disease</article-title><source>Neurobiology of Aging</source><volume>96</volume><fpage>233</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2020.08.007</pub-id><pub-id pub-id-type="pmid">33039901</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Młynarski</surname><given-names>WF</given-names></name><name><surname>Hermundstad</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adaptive coding for dynamic sensory inference</article-title><source>eLife</source><volume>7</volume><elocation-id>e32055</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.32055</pub-id><pub-id pub-id-type="pmid">29988020</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteforte</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dynamical entropy production in spiking neuron networks in the balanced state</article-title><source>Physical Review Letters</source><volume>105</volume><elocation-id>268104</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevLett.105.268104</pub-id><pub-id pub-id-type="pmid">21231716</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Northoff</surname><given-names>G</given-names></name><name><surname>Tumati</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>“Average is good, extremes are bad” – non-linear inverted U-shaped relationship between neural mechanisms and functionality of mental features</article-title><source>Neuroscience &amp; Biobehavioral Reviews</source><volume>104</volume><fpage>11</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2019.06.030</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyberg</surname><given-names>L</given-names></name><name><surname>Lövdén</surname><given-names>M</given-names></name><name><surname>Riklund</surname><given-names>K</given-names></name><name><surname>Lindenberger</surname><given-names>U</given-names></name><name><surname>Bäckman</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Memory aging and brain maintenance</article-title><source>Trends in Cognitive Sciences</source><volume>16</volume><fpage>292</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/j.tics.2012.04.005</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orbán</surname><given-names>G</given-names></name><name><surname>Berkes</surname><given-names>P</given-names></name><name><surname>Fiser</surname><given-names>J</given-names></name><name><surname>Lengyel</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neural variability and sampling-based probabilistic representations in the visual cortex</article-title><source>Neuron</source><volume>92</volume><fpage>530</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.09.038</pub-id><pub-id pub-id-type="pmid">27764674</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>DC</given-names></name><name><surname>Polk</surname><given-names>TA</given-names></name><name><surname>Park</surname><given-names>R</given-names></name><name><surname>Minear</surname><given-names>M</given-names></name><name><surname>Savage</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Aging reduces neural specialization in ventral visual cortex</article-title><source>PNAS</source><volume>101</volume><fpage>13091</fpage><lpage>13095</lpage><pub-id pub-id-type="doi">10.1073/pnas.0405148101</pub-id><pub-id pub-id-type="pmid">15322270</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poil</surname><given-names>SS</given-names></name><name><surname>Hardstone</surname><given-names>R</given-names></name><name><surname>Mansvelder</surname><given-names>HD</given-names></name><name><surname>Linkenkaer-Hansen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Critical-state dynamics of avalanches and oscillations jointly emerge from balanced excitation/inhibition in neuronal networks</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>9817</fpage><lpage>9823</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5990-11.2012</pub-id><pub-id pub-id-type="pmid">22815496</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porges</surname><given-names>EC</given-names></name><name><surname>Woods</surname><given-names>AJ</given-names></name><name><surname>Edden</surname><given-names>RAE</given-names></name><name><surname>Puts</surname><given-names>NAJ</given-names></name><name><surname>Harris</surname><given-names>AD</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Garcia</surname><given-names>AM</given-names></name><name><surname>Seider</surname><given-names>TR</given-names></name><name><surname>Lamb</surname><given-names>DG</given-names></name><name><surname>Williamson</surname><given-names>JB</given-names></name><name><surname>Cohen</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Frontal gamma-aminobutyric acid concentrations are associated with cognitive performance in older adults</article-title><source>Biological Psychiatry Cognitive Neuroscience and Neuroimaging</source><volume>2</volume><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.bpsc.2016.06.004</pub-id><pub-id pub-id-type="pmid">28217759</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porges</surname><given-names>EC</given-names></name><name><surname>Woods</surname><given-names>AJ</given-names></name><name><surname>Lamb</surname><given-names>DG</given-names></name><name><surname>Williamson</surname><given-names>JB</given-names></name><name><surname>Cohen</surname><given-names>RA</given-names></name><name><surname>Edden</surname><given-names>RAE</given-names></name><name><surname>Harris</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Impact of tissue correction strategy on GABA-edited MRS findings</article-title><source>NeuroImage</source><volume>162</volume><fpage>249</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.08.073</pub-id><pub-id pub-id-type="pmid">28882635</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porges</surname><given-names>EC</given-names></name><name><surname>Jensen</surname><given-names>G</given-names></name><name><surname>Foster</surname><given-names>B</given-names></name><name><surname>Edden</surname><given-names>RA</given-names></name><name><surname>Puts</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The trajectory of cortical GABA across the lifespan, an individual participant data meta-analysis of edited MRS studies</article-title><source>eLife</source><volume>10</volume><elocation-id>e62575</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.62575</pub-id><pub-id pub-id-type="pmid">34061022</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2013">2013</year><data-title>R: A language and environment for statistical computing</data-title><publisher-name>R Foundation for Statistical Computing</publisher-name><publisher-loc>Vienna, Austria</publisher-loc><ext-link ext-link-type="uri" xlink:href="https://www.r-project.org">https://www.r-project.org</ext-link></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieck</surname><given-names>JR</given-names></name><name><surname>Rodrigue</surname><given-names>KM</given-names></name><name><surname>Boylan</surname><given-names>MA</given-names></name><name><surname>Kennedy</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Age-related reduction of BOLD modulation to cognitive difficulty predicts poorer task accuracy and poorer fluid reasoning ability</article-title><source>NeuroImage</source><volume>147</volume><fpage>262</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.12.022</pub-id><pub-id pub-id-type="pmid">27979789</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieck</surname><given-names>JR</given-names></name><name><surname>DeSouza</surname><given-names>B</given-names></name><name><surname>Baracchini</surname><given-names>G</given-names></name><name><surname>Grady</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Reduced modulation of BOLD variability as a function of cognitive load in healthy aging</article-title><source>Neurobiology of Aging</source><volume>112</volume><fpage>215</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2022.01.010</pub-id><pub-id pub-id-type="pmid">35240490</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riesenhuber</surname><given-names>M</given-names></name><name><surname>Poggio</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Hierarchical models of object recognition in cortex</article-title><source>Nature Neuroscience</source><volume>2</volume><fpage>1019</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1038/14819</pub-id><pub-id pub-id-type="pmid">10526343</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Serre</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><source>A Theory of Object Recognition: Computations and Circuits in the Feedforward Path of the Ventral Stream in Primate Visual Cortex</source><publisher-name>Semantic Scholar</publisher-name></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serre</surname><given-names>T</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name><name><surname>Poggio</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007a</year><article-title>A feedforward architecture accounts for rapid categorization</article-title><source>PNAS</source><volume>104</volume><fpage>6424</fpage><lpage>6429</lpage><pub-id pub-id-type="doi">10.1073/pnas.0700622104</pub-id><pub-id pub-id-type="pmid">17404214</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serre</surname><given-names>T</given-names></name><name><surname>Wolf</surname><given-names>L</given-names></name><name><surname>Bileschi</surname><given-names>S</given-names></name><name><surname>Riesenhuber</surname><given-names>M</given-names></name><name><surname>Poggio</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007b</year><article-title>Robust object recognition with cortex-like mechanisms</article-title><source>IEEE Transactions on Pattern Analysis and Machine Intelligence</source><volume>29</volume><fpage>411</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1109/TPAMI.2007.56</pub-id><pub-id pub-id-type="pmid">17224612</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shew</surname><given-names>WL</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Roy</surname><given-names>R</given-names></name><name><surname>Plenz</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Information capacity and transmission are maximized in balanced cortical networks with neuronal avalanches</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4637-10.2011</pub-id><pub-id pub-id-type="pmid">21209189</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmonite</surname><given-names>M</given-names></name><name><surname>Carp</surname><given-names>J</given-names></name><name><surname>Foerster</surname><given-names>BR</given-names></name><name><surname>Ossher</surname><given-names>L</given-names></name><name><surname>Petrou</surname><given-names>M</given-names></name><name><surname>Weissman</surname><given-names>DH</given-names></name><name><surname>Polk</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Age-related declines in occipital gaba are associated with reduced fluid processing ability</article-title><source>Academic Radiology</source><volume>26</volume><fpage>1053</fpage><lpage>1061</lpage><pub-id pub-id-type="doi">10.1016/j.acra.2018.07.024</pub-id><pub-id pub-id-type="pmid">30327163</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="software"><person-group person-group-type="author"><collab>umich-tpolk-lab</collab></person-group><year iso-8601-date="2021">2021</year><data-title>DynamicRecoveryPaper</data-title><version designator="9a3e04e">9a3e04e</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/umich-tpolk-lab/DynamicRecoveryPaper">https://github.com/umich-tpolk-lab/DynamicRecoveryPaper</ext-link></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Hateren</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Real and optimal neural images in early vision</article-title><source>Nature</source><volume>360</volume><fpage>68</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/360068a0</pub-id><pub-id pub-id-type="pmid">1436076</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waschke</surname><given-names>L</given-names></name><name><surname>Kloosterman</surname><given-names>NA</given-names></name><name><surname>Obleser</surname><given-names>J</given-names></name><name><surname>Garrett</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Behavior needs neural variability</article-title><source>Neuron</source><volume>109</volume><fpage>751</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2021.01.023</pub-id><pub-id pub-id-type="pmid">33596406</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Waschke</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Single-Neuron Spiking Variability in Hippocampus Dynamically Tracks Sensory Content during Memory Formation in Humans</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.02.23.529684</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Ggplot2: Elegant Graphics for Data Analysis</source><publisher-name>Springer</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-319-24277-4</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolrich</surname><given-names>MW</given-names></name><name><surname>Ripley</surname><given-names>BD</given-names></name><name><surname>Brady</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Temporal autocorrelation in univariate linear modeling of FMRI data</article-title><source>NeuroImage</source><volume>14</volume><fpage>1370</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1006/nimg.2001.0931</pub-id><pub-id pub-id-type="pmid">11707093</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zuo</surname><given-names>XN</given-names></name><name><surname>Ng</surname><given-names>KK</given-names></name><name><surname>Chong</surname><given-names>JSX</given-names></name><name><surname>Shim</surname><given-names>HY</given-names></name><name><surname>Ong</surname><given-names>MQW</given-names></name><name><surname>Loke</surname><given-names>YM</given-names></name><name><surname>Choo</surname><given-names>BL</given-names></name><name><surname>Chong</surname><given-names>EJY</given-names></name><name><surname>Wong</surname><given-names>ZX</given-names></name><name><surname>Hilal</surname><given-names>S</given-names></name><name><surname>Venketasubramanian</surname><given-names>N</given-names></name><name><surname>Tan</surname><given-names>BY</given-names></name><name><surname>Chen</surname><given-names>CLH</given-names></name><name><surname>Zhou</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distinct BOLD variability changes in the default mode and salience networks in Alzheimer’s disease spectrum and associations with cognitive decline</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>6457</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-63540-4</pub-id><pub-id pub-id-type="pmid">32296093</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Lapedriza</surname><given-names>A</given-names></name><name><surname>Khosla</surname><given-names>A</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name><name><surname>Torralba</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Places: a 10 million image database for scene recognition</article-title><source>IEEE Transactions on Pattern Analysis and Machine Intelligence</source><volume>40</volume><fpage>1452</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1109/TPAMI.2017.2723009</pub-id><pub-id pub-id-type="pmid">28692961</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83865.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ip</surname><given-names>I Betina</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.09.14.507785" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.09.14.507785"/></front-stub><body><p>This study by Lalwani et al. combines multiple complementary neuroscientific methods to understand the neural response to visual stimulus complexity in the human brain across lifespan. Lalwani and colleagues provide important and convincing evidence, drawing from appropriate and validated methodology. The manuscript has been comprehensively revised and now includes key control analyses, improved content throughout and clarifications. The study is of broad interest to neuroscientists and biologists interested in aging and sensory processing.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83865.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ip</surname><given-names>I Betina</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ip</surname><given-names>I Betina</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Zhang</surname><given-names>Ru-Yuan</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220qvk04</institution-id><institution>Shanghai Jiao Tong University</institution></institution-wrap><country>China</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.09.14.507785">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.09.14.507785v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The modulation of neural variability reflects aging, GABA and behavior&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including I. Betina Ip as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Ru-Yuan Zhang (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions (for the authors):</p><p>1. Greater effort can be made to make this paper of broader appeal. In the introduction unpack more the specific approach and relate it to more common measures of the hemodynamic response.</p><p>2. The MRS element appears generally well conducted, but more information should be provided. (a) What were the shim values for the voxels in the different groups? (b) What was the quality control (line 217)? (c) How were voxels positioned beyond centering over peak activation? Figure 1 suggests voxels were rotated in at least two planes based on anatomy. This information is missing from the manuscript. (d) A separate water peak estimate was conducted as described in the supplements, but it is not clear whether an additional PRESS scan was acquired. Please clarify. (e) Move the supplemental information about tissue-corrected GABA measurements to the main text. Otherwise, lines 212 to 221 make it somewhat ambiguous as to which GABA measurement was used in subsequent analyses.</p><p>3. It isn't clear to me how the measure of BOLDsd relates to conventional glm-approaches that isolate regions with stimulus preference. As far as the data shows, the BOLDsd approach does not isolate object-selective regions. Please lay out in more detail the rationale for using BOLDsd instead of conventional GLM contrast in the introduction; report the result of the glm contrast faces&gt;houses in percentage BOLD-signal change and discuss their results in light of the different analyses approaches. This would also help broaden the accessibility of your article.</p><p>4. Baseline GABA+ and the task-condition effect on BOLD variability differed between age groups. Combining the two groups to then test for a relationship between GABA and the task-condition effect on BOLD variability can suggest a relationship that may be explained by age alone. The analyses should be repeated with age as a nuisance regressor. Along these lines, Figure 3 shows separate trend lines for the two groups, but the effect was reported across both groups in the text. The figure implies that both groups independently exhibit a relationship, but that is not the case.</p><p>5. Lines 173-174. The lorazepam manipulation is an important feature of the study. However, it is not clear why the two different dosages (.5 or 1 mg) were used and how many participants from each age group received which dosages. Also, were these dosages administered equally across individuals with different baseline GABA levels? Additional analyses should be reported to address whether the different dosages had different effects on BOLD variability across age groups and baseline GABA levels.</p><p>6. I am concerned about the definition of neural variability. In electrophysiological studies, neural variability can be defined as Poisson-like spike count variability. In the fMRI world, however, there is no consensus on what neural variability is. There are at least three definitions. One is the variability (e.g., std) of the voxel response time series as used here and in the resting fMRI world. The second is to regress out the stimulus-evoked activation and only calculate the std of residuals (e.g., background variability). The third is to calculate variability of trial-by-trial variability of β estimates of general linear modeling. It currently remains unclear the relations between these three types of variability and other factors. It also remains unclear the links between neuronal variability and voxel variability. I don't think the computational principles discovered in neuronal variability also apply to voxel responses. I hope the authors can acknowledge their differences and discuss their differences.</p><p>7. If I understand it correctly, the positive relationship between stimulus complexity and voxel variability has been found in the author's previous work. Thus, the claims in the abstract in lines 14-15, and section 1 in results are exaggerated. The results simply replicate the findings in the previous work. This should be clearly stated.</p><p>8. It is difficult for me to comprehend the U-shaped account of baseline GABA and shift in deltaSDBOLD. If deltaSDBOLD per se is good, as evidenced by the positive relationship between brainscore and visual sensitivity as shown in Figure 5b and the discussion in lines 432-440, why the brain should decrease deltaSDBOLD ?? or did I miss something? I understand that &quot;average is good, outliers are bad&quot;. But a more detailed theory is needed to account for such effects. Relatedly, can you show the relationship between the shift of deltaSDBOLD (i.e., the δ of deltaSDBOLD) and visual performance?</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Greater effort can be made to make this paper of broader appeal. In the introduction unpack more the specific approach and relate it to more common measures of the hemodynamic response. The MRS element appears generally well conducted, although basic information on data acquisition and spectral quality is missing.</p><p>– 81. What determined which participants were in which of the 3 subsets? Please name the decision criteria.</p><p>– What determines the cut-off point for old and young participants?</p><p>– 82. Participants – should include sex. Were participants screened for typical MRS exclusion criteria?</p><p>– 89. Does the power analysis refer to a specific subset? It could be subset 3 (38 older and 36 younger) but I am not sure. Please state the sample size and the subset.</p><p>– 95. I found the text describing the protocol and Figure 1 confusing. All three subsets took part in 3 sessions, but only subset 3 took part in the visual discrimination task. Subset 1 would have taken part in 2 imaging sessions, 1 for the drug and 1 for the placebo. Were those two imaging sessions identical (fMRI + MRS)? This needs to be laid out in detail.</p><p>– What exactly were the cognitive and behavioural testing components for Subset 1 and 2? Also, please note the average difference in days between sessions 1-3 for cohorts.</p><p>– Figure 1. I like the use of icons and would suggest an alternative icon to a person with a walking stick to represent people above 77 yo – the alternative could be the same icon as the younger population with a different shading/color.</p><p>– 104. Not sufficient information to understand what was done here. More information is needed on the testing, such as whether there was a head and chin rest, what was the viewing distance, whether the room was illuminated or dark etc.</p><p>– 143. What was the spatial resolution of the EPI scan?</p><p>– 146. Was the whole fMRI session 6 min- how long did the whole session last and was the fMRI scan always in the same order?</p><p>– 154. What was the average hit rate for the target trials, and were there differences across age groups?</p><p>– 156. MRS session – how were the voxels placed? Did you run another visual task scan to provide a map in the MRS session? The text suggests this is the case, but it is not explicitly mentioned. If you didn't use a localiser map from the same session, please describe how the &quot;person-specific task-activations&quot; were used to guide voxel placement.</p><p>– What were participants doing during the MRS scan and how many spectral averages were collected? Please include the document &quot;minimum reporting standards&quot; for MRS.</p><p>– 168. How was this subset chosen, and how were the drug and placebo randomised? Was the experimenter blind to the randomisation?</p><p>– 173. Why were there two dosages and were low vs high doses balanced?</p><p>– 183. 7 mm is not the default smoothing in FEAT.</p><p>– 192. Methodological detail missing for quantification of BOLDsd. Please refrain from referring to the previous paper. All information required for replicating the study should be in this current paper.</p><p>– 208. cite paper for MM contamination in the occipital cortex by Harris et al., 2015.</p><p>– 217. 'quality control check' define and report values.</p><p>– 263. It isn't clear to me how the measure of BOLDsd relates to conventional glm-approaches that isolate regions with stimulus preference. As far as the data shows, the BOLDsd approach does not isolate object-selective regions. Please lay out in more detail the rationale for using BOLDsd instead of conventional GLM contrast in the introduction; report the result of the glm contrast faces&gt;houses in percentage BOLD-signal change and discuss their results in light of the different analyses approaches. This would also help broaden the accessibility of your article.</p><p>– 288-289 This sentence struck me as odd and makes the analysis sound post hoc.</p><p>– 314: I'm not sure how the data in Figure 4 was pulled together, this comes back to Figure 1 where more detail is needed on what exactly different people were tested on, and in what order. Is the baseline GABA from one of the on/off-drug sessions, or is it separate? I am guessing that the y-axis is the difference between placebo and drug in fMRI, but that the x-axis is from a separate off-drug MRS session. Whatever the case needs to be clarified.</p><p>– GABA levels should be noted with units on the axis GABA+/water IU.</p><p>– 319: Why is the change due to drug consistent with an inverted-U account if the change simply describes a negative relationship of BOLDsd to baseline GABA?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. Baseline GABA+ and the task-condition effect on BOLD variability differed between age groups. Combining the two groups to then test for a relationship between GABA and the task-condition effect on BOLD variability can suggest a relationship that may be explained by age alone. The analyses should be repeated with age as a nuisance regressor. Along these lines, Figure 3 shows separate trend lines for the two groups, but the effect was reported across both groups in the text. The figure implies that both groups independently exhibit a relationship, but that is not the case.</p><p>2. Further information should be included about the MRS imaging approach. (1) What were the shim values for the voxels in the different groups? (2) What was the quality control (line 217)? (3) How were voxels positioned beyond centering over peak activation? Figure 1 suggests voxels were rotated in at least two planes based on anatomy. This information is missing from the manuscript. (4) A separate water peak estimate was conducted as described in the supplements, but it is not clear whether an additional PRESS scan was acquired. Please clarify. (5) Move the supplemental information about tissue-corrected GABA measurements to the main text. Otherwise, lines 212 to 221 make it somewhat ambiguous as to which GABA measurement was used in subsequent analyses.</p><p>3. Lines 173-174. The lorazepam manipulation is an important feature of the study. However, it is not clear why the two different dosages (.5 or 1 mg) were used and how many participants from each age group received which dosages. Also, were these dosages administered equally across individuals with different baseline GABA levels? Additional analyses should be reported to address whether the different dosages had different effects on BOLD variability across age groups and baseline GABA levels.</p><p>4. Lines 158-160. Please include the scanning parameters for the T1-weighted MRI in the Methods section even if they are reported in a previous publication.</p><p>5. Lines 308-310. Were the bilateral fusiform, calcarine and lingual cortex captured within the MRS voxel?</p><p>6. Lines 132-133. Further information should be provided about the factor loadings used for computing the visual sensory factor. How exactly was performance used to determine these loadings?</p><p>7. Was participant's visual acuity assessed? If so, please include whether acuity was matched between age groups.</p><p>8. Please indicate left and right in the brain images in Figures 2 and 3.</p><p>9. Specifying &quot;visual processing&quot; in the title of the paper would be appropriate given the focus on the visual system.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. Given the computation of neural variability is the key in this paper, I strongly recommend the authors to detail the calculation of SDBOLD. It is inconvenient to search the reference.</p><p>2. Given such a rich dataset and diverse types of analyses, readers easily lost track of the results. I particularly like the first paragraph of the Discussion. It clearly summarizes all the key findings in this paper. I would suggest doing it in the last paragraph of the introduction such that readers can set up expectations and better interpret the follow-up result part.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Modulation of brain signal variability in visual cortex reflects aging, GABA, and behavior&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Joshua Gold (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>1) Further experimental details on the visual display, the MRS water reference, plus example MRS spectra need to be added to the manuscript.</p><p>2) Demonstration of regional specificity of the MRS results to the ventral visual cortex voxel has been requested.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The authors have done a thorough job of addressing the comments. My comments are below.</p><p>Line 548: &quot;where the laptop was placed at a standard&quot; needs to state the exact viewing distance of the screen to the participant.</p><p>Example spectra, at group level if possible, should be added to the Supplementary materials to indicate the quality of the MRS.</p><p>How specific are the GABA+ effects to the visual cortex voxels? It appears that they should be highly specific, given the visual task, but the evidence has not been supplied. Given the number of additional voxels that have been collected, it seems straightforward to assess region specificity. Could the authors please use a control region from one of the other MRS voxels to provide support for a region specificity of the GABA+ results in the ventral visual cortex, for example, the right sensorimotor cortex?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors have done a commendable job addressing the majority of my concerns.</p><p>Regarding my previous comment #2, I am still unclear on how water was measured. I found where the water peak fitting was described (Ln169-170). Presumably, this was using the residual water signal in the edited spectra since a separate unsuppressed water scan was not acquired. It's possible this was explained more completely in the supplements, but I am having trouble finding the supplemental materials that accompany the revised manuscript. Could you please clarify whether the residual water signal is what was used? This is important given that the raw GABA+/H2O data were reported. Thanks.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83865.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions (for the authors):</p><p>Reviewer #1 (Recommendations for the authors):</p><p>Greater effort can be made to make this paper of broader appeal. In the introduction unpack more the specific approach and relate it to more common measures of the hemodynamic response. The MRS element appears generally well conducted, although basic information on data acquisition and spectral quality is missing.</p></disp-quote><p>Thank you for this important point. We have now included an additional discussion about what is known about the more common univariate/mean-BOLD measure, how it relates to BOLD variability, and why modulation of visual variability is of broad interest (Ln 32-40). Briefly, patterns observed in BOLD signal variability are rarely driven by mean-BOLD differences in our entire body of previous work (see Garrett et al., 2013, <italic>NBR</italic>; Waschke et al., 2021, <italic>Neuron</italic>). To further confirm this in the current study, we performed an additional mean-BOLD based analysis and now present these findings (Ln 286-296, Figure 6, Discussion Ln 391-393) to help support the unique contribution that BOLD variability brings to this research context. Results suggest that <inline-formula><mml:math id="sa2m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> MEAN<sub>BOLD</sub> was larger in older adults vs. younger adults (<inline-formula><mml:math id="sa2m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> exhibited the opposite pattern), but more importantly <inline-formula><mml:math id="sa2m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> MEAN<sub>BOLD</sub> was not correlated with GABA or with visual performance, while <inline-formula><mml:math id="sa2m4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> was. Such a differentiation is also consistent with prior research (Garrett et.al. 2011, 2013, 2015, 2020) finding SD<sub>BOLD</sub> to be far more sensitive to behavioral performance than MEAN<sub>BOLD</sub>.</p><p>Finally, we have also included a reporting table for Magnetic Resonance Spectroscopy (Table 4) and added more details to the Methods section (Ln 609-623).</p><disp-quote content-type="editor-comment"><p>– 81. What determined which participants were in which of the 3 subsets? Please name the decision criteria.</p></disp-quote><p>The three cohorts were collected at different times as part of an ongoing study whose primary target of interest was the role of GABA in neural dedifferentiation (the Michigan Neural Distinctiveness (MiND) study, [Gagnon et al. (2019). BMC Neurology 19(1), 117]) and that underwent revisions as it progressed. The selection of participants in each cohort was therefore essentially random based on when the participants were recruited in the study timeline (Subset 1: Before Feb 2018, Subset 2: Feb – June 2018, Subset 3: June 2018 – Mar 2020). The revision now clarifies this important point. Thanks.</p><disp-quote content-type="editor-comment"><p>– What determines the cut-off point for old and young participants?</p></disp-quote><p>Young participants were 18 to 29 years old while older participants were 65 and older; they were recruited specifically within these ranges.</p><disp-quote content-type="editor-comment"><p>– 82. Participants – should include sex. Were participants screened for typical MRS exclusion criteria?</p></disp-quote><p>The revision now includes the sex distributions across subsets (Table 3). And yes, participants were screened for several exclusion criteria that are now detailed in the methods and material: various disorders, MRI incompatibility, history of alcohol abuse, etc. (Ln 467-490). Our apologies for not including this information in the original manuscript.</p><disp-quote content-type="editor-comment"><p>– 89. Does the power analysis refer to a specific subset? It could be subset 3 (38 older and 36 younger) but I am not sure. Please state the sample size and the subset.</p></disp-quote><p>Yes, it refers to the behavioral part of the study and we have clarified that in the revision. Ln 492-495: “Since, Garrett et.al. (2020) had found a correlation of r=0.47 between modulation of visual variability and behavioral performance within older adults we had 80% power to detect a correlation of r=0.47 between modulation of variability and performance in each age-group within Subset 3 that completed the behavior task.”</p><disp-quote content-type="editor-comment"><p>95. I found the text describing the protocol and Figure 1 confusing. All three subsets took part in 3 sessions, but only subset 3 took part in the visual discrimination task. Subset 1 would have taken part in 2 imaging sessions, 1 for the drug and 1 for the placebo. Were those two imaging sessions identical (fMRI + MRS)? This needs to be laid out in detail.</p><p>– What exactly were the cognitive and behavioural testing components for Subset 1 and 2? Also, please note the average difference in days between sessions 1-3 for cohorts.</p></disp-quote><p>We have updated our figure and methods to better clarify the sessions and have included more information about the original study design (Figure 7, Table 3, Ln 504529). Thanks for the suggestion. Other details about the original study that are less relevant to the current paper are described in Gagnon et al. (2019). BMC Neurology 19(1), 1-17.</p><disp-quote content-type="editor-comment"><p>– Figure 1. I like the use of icons and would suggest an alternative icon to a person with a walking stick to represent people above 77 yo – the alternative could be the same icon as the younger population with a different shading/color.</p></disp-quote><p>Great idea, we have done so in Figure 7.</p><disp-quote content-type="editor-comment"><p>– 104. Not sufficient information to understand what was done here. More information is needed on the testing, such as whether there was a head and chin rest, what was the viewing distance, whether the room was illuminated or dark etc.</p></disp-quote><p>Thanks, also done.</p><p>Ln 536-539: “Tasks were completed in a well-lit room where the laptop was placed at a standard (same for all participants) comfortable viewing distance. Participants were instructed to not lean forward or squint when completing the tasks.”</p><disp-quote content-type="editor-comment"><p>– 143. What was the spatial resolution of the EPI scan?</p></disp-quote><p>3 × 3 × 3 mm, now included in the revision (Ln 587). Thanks.</p><disp-quote content-type="editor-comment"><p>– 146. Was the whole fMRI session 6 min- how long did the whole session last and was the fMRI scan always in the same order?</p></disp-quote><p>The fMRI sessions lasted approximately 45 min, including the acquisition of a structural image and other task-based and resting state functional data. The order of visual and motor fMRI task-runs was counterbalanced across participants and was always done after the structural, resting-state, and auditory scan. The revision now includes these details too (Ln 599-603). Thanks for the suggestion.</p><disp-quote content-type="editor-comment"><p>– 154. What was the average hit rate for the target trials, and were there differences across age groups?</p></disp-quote><p>There were only 6 target trials that were extremely easy and only designed to ensure participant attention, so almost everyone had a perfect hit rate. We also found no difference between the age-groups for these catch trials (Ln 598).</p><disp-quote content-type="editor-comment"><p>– 156. MRS session – how were the voxels placed? Did you run another visual task scan to provide a map in the MRS session? The text suggests this is the case, but it is not explicitly mentioned. If you didn't use a localiser map from the same session, please describe how the &quot;person-specific task-activations&quot; were used to guide voxel placement.</p><p>– What were participants doing during the MRS scan and how many spectral averages were collected? Please include the document &quot;minimum reporting standards&quot; for MRS.</p></disp-quote><p>The revision now explains in greater detail how the voxels were placed and other MRS details along with the minimum reporting standards table (Table 4, Ln 609-623). Thanks for the suggestion.</p><p>Ln 609-623: “For each participant, we used their fMRI task sessions to compute an activation map for a face and house viewing vs. fixation contrast. These activation maps provided visual guidance to help with the voxel placement. Specifically, the fMRI technician used the activation maps to place the large MRS voxels so that they were centered roughly at the peak of the activation while not extending outside the brain. The voxels were rotated such that one of the edges was almost parallel and close to the cerebellum-cortical boundary minimizing overlap with dura, parietal and angular regions.</p><p>It was also rotated in the inferior-posterior plane to maximize coverage in the posterior occipital regions along with the fusiform and parahippocampal gyrus while minimizing overlap with the hippocampus. Note that these are large voxels, and the primary concern is to minimize overlap with non-cortical regions like ventricles, brainstem, dura, and cortex-cerebellum boundary that affect contamination and good shim (FWHM less than 15) while maximizing the coverage of region of interest. In this case the right and left ventrovisual regions were targeted and the voxel covered parts of fusiform, inferior occipital, calcarine, lingual, and parahippocampal gyrus. It was shifted away from the midline as much as possible without covering the dura. The voxel overlap across participants is shown in Figure 1. We used a MEGA-PRESS sequence with the following parameters to obtain MR spectra: TE=68ms (TE1=15ms, TE2=53ms), TR=1.8sec, spec. width=5kHz, Frequency selective editing pulses (14ms) applied at 1.9ppm (ON) &amp; 7.46 ppm (OFF), 256 transients (128 ON interleaved with 128 OFF) of 4096 data points.”</p><disp-quote content-type="editor-comment"><p>– 168. How was this subset chosen, and how were the drug and placebo randomised? Was the experimenter blind to the randomisation?</p></disp-quote><p>The first set of participants to complete the study received the drug-manipulation. The drug and placebo order were counterbalanced across participants. This was only a single-blind study; although the participants did not know whether they were in the drug or placebo condition, the experimenter did (Ln 635-637).</p><disp-quote content-type="editor-comment"><p>– 173. Why were there two dosages and were low vs high doses balanced?</p><p>– 183. 7 mm is not the default smoothing in FEAT.</p></disp-quote><p>We’ve corrected this error in the revision (Ln 645), thanks.</p><disp-quote content-type="editor-comment"><p>– 192. Methodological detail missing for quantification of BOLDsd. Please refrain from referring to the previous paper. All information required for replicating the study should be in this current paper.</p></disp-quote><p>Apologies, we’ve now added this information to the revision, thanks.</p><p>Ln 656-659: “After preprocessing the fMRI data, we normalized all blocks for each condition (houses and faces separately) such that the overall 4D mean across brain and the block was the same. Then, for each voxel, we subtracted the block mean and concatenated the time-series across all blocks for that condition. The standard deviation in this time-series during each of the conditions (faces and houses) was computed at each voxel for each participant (similar to previous work3). Modulation of variability (<inline-formula><mml:math id="sa2m5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub>) was computed as the difference between the two conditions (SD<sub>BOLD-HOUSES</sub> – SD<sub>BOLD-FACES</sub>) at each of the voxels in a grey matter volume mask. Similarly, <inline-formula><mml:math id="sa2m6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> on drug was computed for the subset of participants who were administered lorazepam.”</p><disp-quote content-type="editor-comment"><p>– 208. cite paper for MM contamination in the occipital cortex by Harris et al., 2015.</p></disp-quote><p>Done (Ln 442)</p><disp-quote content-type="editor-comment"><p>– 217. 'quality control check' define and report values.</p></disp-quote><p>Also done (Ln 683-684): “Based on a quality control check of the spectra (flagged if the value was more than 3 standard deviations from mean, the fit error was greater than 10% for water, or the CSF fraction was more than 20%), we flagged and discarded three right and seven left GABA values.”</p><disp-quote content-type="editor-comment"><p>– 263. It isn't clear to me how the measure of BOLDsd relates to conventional glm-approaches that isolate regions with stimulus preference. As far as the data shows, the BOLDsd approach does not isolate object-selective regions. Please lay out in more detail the rationale for using BOLDsd instead of conventional GLM contrast in the introduction; report the result of the glm contrast faces&gt;houses in percentage BOLD-signal change and discuss their results in light of the different analyses approaches. This would also help broaden the accessibility of your article.</p></disp-quote><p>The revised Introduction tries to do a better job of motivating the use of BOLDsd and its relationship to more traditional measures of mean signal change (Ln 32-40). We’ve also added the results based on mean BOLD (Ln 286-296, Figure 6, Discussion Ln 391393). Briefly, our results suggest that <inline-formula><mml:math id="sa2m7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> MEAN<sub>BOLD</sub> is actually larger in older adults vs. younger adults (<inline-formula><mml:math id="sa2m8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> exhibited the opposite pattern), but more importantly, <inline-formula><mml:math id="sa2m9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> MEAN<sub>BOLD</sub> is not correlated with GABA or with visual performance. This is also consistent with prior research that found MEAN<sub>BOLD</sub> to be relatively insensitive to behavioral performance (Garrett et.al. 2011, 2013, 2015, 2020).</p><disp-quote content-type="editor-comment"><p>– 288-289 This sentence struck me as odd and makes the analysis sound post hoc.</p></disp-quote><p>Good point. We’ve modified this sentence to try to make it read better.</p><p>Now Ln 155-158: “We further confirmed that the strongest task-condition effects on SD<sub>BOLD</sub> are present in the visual cortex and our GABA estimates are also in the taskrelevant visual cortex. Thus, we restricted all further analyses within an anatomically defined task-relevant visual mask in all subjects (see Methods) rather than investigate it in the whole-brain and in task irrelevant regions.”</p><disp-quote content-type="editor-comment"><p>– 314: I'm not sure how the data in Figure 4 was pulled together, this comes back to Figure 1 where more detail is needed on what exactly different people were tested on, and in what order. Is the baseline GABA from one of the on/off-drug sessions, or is it separate? I am guessing that the y-axis is the difference between placebo and drug in fMRI, but that the x-axis is from a separate off-drug MRS session. Whatever the case needs to be clarified.</p></disp-quote><p>The GABA MRS sessions were separate from the fMRI sessions and were always offdrug. And yes, the x-axis is the GABA estimate from the off-drug MRS session while the y-axis is the difference in <inline-formula><mml:math id="sa2m10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> on and off drug. We tried to clarify this in the revision. Thanks for the suggestion (Ln 186-188 and Figure 4).</p><disp-quote content-type="editor-comment"><p>– GABA levels should be noted with units on the axis GABA+/water IU.</p></disp-quote><p>Done, thanks (Figure 3a, 4 and 5a).</p><disp-quote content-type="editor-comment"><p>– 319: Why is the change due to drug consistent with an inverted-U account if the change simply describes a negative relationship of BOLDsd to baseline GABA?</p></disp-quote><p>The drug-related shift in <inline-formula><mml:math id="sa2m11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> extends from +15 to -15 and has a negative relationship with baseline GABA. Thus, participants with low baseline GABA had low levels of <inline-formula><mml:math id="sa2m12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> and experienced an increase in <inline-formula><mml:math id="sa2m13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> on the drug (i.e., when GABA activity was increased). However, participants with higher baseline GABA levels and higher <inline-formula><mml:math id="sa2m14"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> experienced a no-change or even a decrease in <inline-formula><mml:math id="sa2m15"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> on drug (i.e. when GABA was increased beyond optimal levels). This is consistent with the inverted-U account. We have added an additional explanation on Ln 355-362 in manuscript as well.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83865-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. Baseline GABA+ and the task-condition effect on BOLD variability differed between age groups. Combining the two groups to then test for a relationship between GABA and the task-condition effect on BOLD variability can suggest a relationship that may be explained by age alone. The analyses should be repeated with age as a nuisance regressor. Along these lines, Figure 3 shows separate trend lines for the two groups, but the effect was reported across both groups in the text. The figure implies that both groups independently exhibit a relationship, but that is not the case.</p></disp-quote><p>We have now clarified in the text that indeed the relationship between GABA and <inline-formula><mml:math id="sa2m16"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> shown in Figure 3 is significant within each age-group (Line 173-175). Further, the initial, full model included both age-group and GABA as regressors and found that both had a significant effect (while the Age-group x GABA interaction was not significant). Therefore, the effect of age on <inline-formula><mml:math id="sa2m17"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> does not completely explain the observed relationship between GABA and <inline-formula><mml:math id="sa2m18"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD,</sub> as this effect is significant in both age-groups individually and in the whole sample even when variance explained by age is accounted for. The revision tries to make these points clearer (Ln 331-335).</p><disp-quote content-type="editor-comment"><p>2. Further information should be included about the MRS imaging approach. (1) What were the shim values for the voxels in the different groups? (2) What was the quality control (line 217)? (3) How were voxels positioned beyond centering over peak activation? Figure 1 suggests voxels were rotated in at least two planes based on anatomy. This information is missing from the manuscript. (4) A separate water peak estimate was conducted as described in the supplements, but it is not clear whether an additional PRESS scan was acquired. Please clarify.</p></disp-quote><p>The revision now includes all details to address these concerns as well as the table of &quot;minimum reporting standards&quot; for MRS has been included in the supplementary attachments (Table 4). No additional water-unsuppressed PRESS scan was obtained.</p><p>Ln 609 – 623 – The MRS data was obtained from 3cm x 3cm x 3cm voxels placed in the left and right ventrovisual cortex. For each participant, we used their fMRI task sessions to compute an activation map for a face and house viewing vs. fixation contrast. These activation maps provided visual guidance to help with the voxel placement. Specifically, the MRI technician used the activation maps to place the large MRS voxels so that they were centered roughly at the peak of the activation while not extending outside the brain. The voxels were rotated such that one of the edges was almost parallel and close to the cerebellum-cortical boundary minimizing overlap with dura, parietal and angular regions. It was also rotated in the inferior-posterior plane to maximize coverage in the posterior occipital regions along with the fusiform and parahippocampal gyrus while minimizing overlap with the hippocampus. Note that these are large voxels, and the primary concern is to minimize overlap with non-cortical regions like ventricles, brainstem, dura, and cortex-cerebellum boundary that affect contamination and good shim (FWHM less than 15) while maximizing the coverage of region of interest. In this case the right and left ventrovisual regions were targeted and the voxel covered parts of fusiform, inferior occipital, calcarine, lingual, and parahippocampal gyrus. It was shifted away from the midline as much as possible without covering the dura. The voxel overlap across participants is shown in Figure 7.</p><p>Ln 683-685 – Based on a quality control check of the spectra (flagged if the value was more than 3 standard deviations from the mean, the fit error was greater than 10% for water, or the CSF fraction was more than 20%), we flagged and discarded three right and seven left GABA values.</p><disp-quote content-type="editor-comment"><p>5) Move the supplemental information about tissue-corrected GABA measurements to the main text. Otherwise, lines 212 to 221 make it somewhat ambiguous as to which GABA measurement was used in subsequent analyses.</p></disp-quote><p>Done, thanks.</p><p>Ln 148-155: “GABA+ levels were also significantly lower in older adults compared to younger adults after correcting for tissue-composition differences (t(131.9) = -3.13, p = 0.002, Cohen’s d = 0.53) after applying Harris et al.'s α tissue correction procedure. These results suggest that the differences in tissue composition do not explain the observed lower GABA levels in older adults. Since, raw GABA+/H2O levels were highly correlated with α tissue composition-corrected GABA levels (r(131) = 0.88, p &lt; 2.2e-16), all results presented below were based on the raw GABA+/H2O levels.”</p><disp-quote content-type="editor-comment"><p>3. Lines 173-174. The lorazepam manipulation is an important feature of the study. However, it is not clear why the two different dosages (.5 or 1 mg) were used and how many participants from each age group received which dosages. Also, were these dosages administered equally across individuals with different baseline GABA levels? Additional analyses should be reported to address whether the different dosages had different effects on BOLD variability across age groups and baseline GABA levels.</p></disp-quote><p>The dosage was assigned randomly (Ln 514, 635) and we did not find any effect of dosage (Ln 195-211).</p><disp-quote content-type="editor-comment"><p>4. Lines 158-160. Please include the scanning parameters for the T1-weighted MRI in the Methods section even if they are reported in a previous publication.</p></disp-quote><p>Done.</p><p>Ln 578-582: “A high-resolution T1-weighted structural image was collected using a 3D fast spoiled gradient echo (SPGR) BRAVO pulse sequence with the following parameters: TR = 12.2 ms; TE = 5.2 ms; TI = 500 ms; flip angle = 15°; FOV = 256 × 256 mm; 156 axial slices with thickness = 1 mm and no spacing; acquisition time = 5 min and voxel size (1 × 1 × 1 mm).”</p><disp-quote content-type="editor-comment"><p>5. Lines 308-310. Were the bilateral fusiform, calcarine and lingual cortex captured within the MRS voxel?</p></disp-quote><p>Yes (Now included Ln 609-623). For each participant, we used their fMRI task sessions to compute an activation map for a face and house viewing vs. fixation contrast. These activation maps provided a visual guidance to help with the voxel placement where the fMRI technician used major anatomical landmarks to place the large MRS voxels centered roughly at the peak of the activation. The voxels were rotated such that one of the edges was almost parallel and close to the cerebellum-cortical boundary minimizing overlap with dura, parietal and angular regions. It was also rotated in the inferiorposterior plane to maximize coverage in the posterior occipital regions along with fusiform and the parahippocampus while minimizing overlap with hippocampus. Note that these are large voxels, and the primary concern is to minimize overlap with noncortical regions like ventricles, brainstem, dura, and cortex-cerebellum boundary that affect contamination and good shim (FWHM less than 15) while maximizing the coverage of region of interest. In this case the right and left ventrovisual regions were targeted and the voxel covered parts of fusiform, infereior occipital region, calcarine, lingual, and parahippocampus. It was shifted away from the midline as much as possible without covering the dura. The voxel overlap across participants is shown in Figure 7.</p><disp-quote content-type="editor-comment"><p>6. Lines 132-133. Further information should be provided about the factor loadings used for computing the visual sensory factor. How exactly was performance used to determine these loadings?</p></disp-quote><p>Done. Each task used a staircase procedure in which more noise was presented after correct trials and less noise was presented after incorrect trials in order to estimate the amount of noise the participant could tolerate. The average level of noise presented for the last 40 trials for each of four task was used as the dependent measure.</p><p>Now Ln 566-582: “Using the MATLAB function factoran, we computed a single visual sensory factor based on this measure from each of the four tasks. The loadings of the tasks on the factor were 0.3 (buildings), 0.8 (faces), 0.5 (objects) and 0.2 (scenes). Since, a higher score on each individual task represents better performance and each loading is positive a higher factor score also reflects better performance. Using principal component analysis (PCA) only one component had an eigen value &gt; 1, explaining 40% of the variance, and the corresponding weights were 0.53 (buildings), 0.8 (faces), 0.7 (objects) and 0.42 (scenes). The scores on this first component were correlated at (r(72) = 0.88, p &lt; 2.2e-16) with the scores on the first factor from the factor analysis. We thus present results based on the factor score.”</p><disp-quote content-type="editor-comment"><p>7. Was participant's visual acuity assessed? If so, please include whether acuity was matched between age groups.</p></disp-quote><p>Good point. We have now included additional analysis (Ln 273-283). Briefly, visual acuity was assessed using the NIH-toolbox and was significantly lower in older adults compared to young. However, controlling for it did not affect the reported findings. Raw visual acuity was significantly lower in older adults (t(56.5) = 3.85, p = 0.0002) as measured by the NIH Visual Acuity task, but it was not correlated with the visual discrimination behavior score (r(72) = -0.03, p = 0.78). This is not surprising as the discrimination task was performed with images presented at a comfortable distance and size to the participant. Moreover, controlling for visual acuity did not alter any of the reported effects. The relationship between both age (F(1,119) = 67.01, p &lt; 3.4e-13) and GABA (F(1,119) = 5.9, p = 0.016) remained robustly associated with visual <inline-formula><mml:math id="sa2m19"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> after controlling for visual acuity and grey matter volume. Moreover, both greater <inline-formula><mml:math id="sa2m20"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub> (rho (36) = 0.41, p = 0.01) and higher GABA levels (rho (36) = 0.35, p = 0.03) were associated with better visual discrimination performance in older adults even after controlling for visual acuity and grey matter volume.</p><disp-quote content-type="editor-comment"><p>8. Please indicate left and right in the brain images in Figures 2 and 3.</p></disp-quote><p>Done, thanks for the suggestion.</p><disp-quote content-type="editor-comment"><p>9. Specifying &quot;visual processing&quot; in the title of the paper would be appropriate given the focus on the visual system.</p></disp-quote><p>Also done.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. Given the computation of neural variability is the key in this paper, I strongly recommend the authors to detail the calculation of SDBOLD. It is inconvenient to search the reference.</p></disp-quote><p>Done (Ln 656-663), thanks for the suggestion. After preprocessing the fMRI data, we normalized all blocks for each condition (houses and faces separately) such that the overall 4D mean across brain and the block was the same. Then, for each voxel, we subtracted the block mean and concatenated the time-series across all blocks for that condition. The standard deviation in this time-series during each of the conditions (faces and houses) was computed at each voxel for each participant. Modulation of variability (<inline-formula><mml:math id="sa2m21"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo stretchy="false">→</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> SD<sub>BOLD</sub>) was computed as the difference between the two conditions (SD<sub>BOLD-Houses</sub> – SD<sub>BOLD-Faces</sub>) at each of the voxels in a grey matter volume mask.</p><disp-quote content-type="editor-comment"><p>2. Given such a rich dataset and diverse types of analyses, readers easily lost track of the results. I particularly like the first paragraph of the Discussion. It clearly summarizes all the key findings in this paper. I would suggest doing it in the last paragraph of the introduction such that readers can set up expectations and better interpret the follow-up result part.</p></disp-quote><p>Done (Ln 79-84), thanks.</p><p>[Editors’ note: what follows is the authors’ response to the second round of review.]</p><disp-quote content-type="editor-comment"><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>Reviewer #1 (Recommendations for the authors):</p><p>The authors have done a thorough job of addressing the comments. My comments are below.</p><p>Line 548: &quot;where the laptop was placed at a standard&quot; needs to state the exact viewing distance of the screen to the participant.</p></disp-quote><p>Now updated on Line 551 “laptop was placed at a fixed (same and measured for all participants) viewing distance of 21 inches.”</p><disp-quote content-type="editor-comment"><p>Example spectra, at group level if possible, should be added to the Supplementary materials to indicate the quality of the MRS.</p><p>How specific are the GABA+ effects to the visual cortex voxels? It appears that they should be highly specific, given the visual task, but the evidence has not been supplied. Given the number of additional voxels that have been collected, it seems straightforward to assess region specificity. Could the authors please use a control region from one of the other MRS voxels to provide support for a region specificity of the GABA+ results in the ventral visual cortex, for example, the right sensorimotor cortex?</p></disp-quote><p>Great point. Indeed, the relationship between ventral visual cortex GABA+ levels and modulation of variability is region specific. Modulation of variability in the visual cortex during a visual task was not associated with the GABA levels in the auditory cortex or motor cortex. On lines 182-189, we now note that:</p><p>Further, we found that tissue-composition corrected auditory GABA+ levels (see Lalwani et.al., 2019 for details of voxel placement) were not associated with modulation of visual variability in the whole sample after controlling for age (F(1,120) = 0.72, p = 0.4) or within older adults alone (r(74) = 0.01, p = 0.9). Similarly, tissue-composition corrected motor GABA+ levels (see Cassady et.al., 2019 for details of voxel placement) were not associated with modulation of visual variability in the whole sample after controlling for age (F(1,120) = 0.52, p = 0.47) or within older adults alone (r(74) = 0.02, p = 0.9), revealing that our GABA+ effects were specific to visual cortex.</p><p>On lines 344-346, we now note:</p><p>Moreover, we found that this relationship was specific to visual cortex (i.e., auditory and motor GABA levels did not predict individual differences in visual ∆SD<sub>BOLD)</sub>.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The authors have done a commendable job addressing the majority of my concerns.</p><p>Regarding my previous comment #2, I am still unclear on how water was measured. I found where the water peak fitting was described (Ln169-170). Presumably, this was using the residual water signal in the edited spectra since a separate unsuppressed water scan was not acquired. It's possible this was explained more completely in the supplements, but I am having trouble finding the supplemental materials that accompany the revised manuscript. Could you please clarify whether the residual water signal is what was used? This is important given that the raw GABA+/H2O data were reported. Thanks.</p></disp-quote><p>Thank you so much for pointing out this. The previous revision was unclear, and we have now updated it appropriately. “Line 641: For water referencing, eight transients of water unsuppressed data were collected at the end of the sequence, resulting in one reference frame where the NEX=8 averaging is applied.”</p></body></sub-article></article>